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CONFERENCE PRESENTATION 
 
On behalf of the Organizing Committee, we would like to welcome you to the Conference 
“Physics & Medicine. Toward a future of integration” in Trento. 
 
 The relationship between physics and medicine has ancient roots that sink to the dawn of medicine 
with the use of physical techniques, like heat and light, to diagnose and treat diseases. In the 17th century, 
with the advent of the experimental method, the mechanistic description of nature was soon extended to 
living creatures. At the University of Padua, when Galileo was still there to teach, started the school of 
iatro-mechanics that was concerned with fundamental questions about the function of the human body 
and the nature of life itself. Along these lines, physics contributed both to the establishment of new 
medical disciplines such as biomechanics, electrophysiology and ophthalmology and supported many 
other clinical practices and medical researches through the development of a huge number of physics-
based devices for clinical measurement, diagnosis and treatment. However, medical physics, as we 
usually understand the term, emerged as a distinct discipline in the 20th century in response to the growing 
use of ionizing radiation in both diagnosis and treatment. The urgent need to associate to the team of 
health professionals dealing with ionizing radiation a physicist with the central role of warrantor of the 
safe and effective use of radiation became soon evident and led to a new health-care profession: medical 
physics. 
 In Italy, the Conference “Conversations on the Relations between Physics and Medicine” held in 
Levico Roncegno Terme (Trento) from September 14th to 19th 1964, was of paramount importance to the 
activation of the Medical Physics services in the healthcare facilities. Moreover that Conference 
emphasized the need for basic training in physics for future physicians thus contributing to the 
establishment of Chairs in Medical Physics at the Schools of Medicine. 
  
The actual Conference  “Physics & Medicine. Toward a future of integration” has been organized by 
the University of Trento, the Azienda Provinciale per i Servizi Sanitari of Trento and the Associazione 
Italiana di Fisica Medica, on the 50th anniversary of the Levico Roncegno Terme event. Since then the 
life sciences experienced a true scientific and technological revolution with significant clinical 
implications demanding to physics and medicine effective patterns of integration . Therefore the goals of 
the meeting are: 
• to review the current status of main topics of medical physics and give a vision of coming 
developments; 
• to consider the profession and the role of the medical physicist projected in the new organizational 
models of health services; 
• to analyze patterns of training and retraining of medical physicists as well as the basic training 
programs for future physicians; 
• to discuss the contribution of research in physics as applied to medicine as an engine for 
innovation in health care; 
 The event is organized in conjunction with the International Day of Medical Physics, proposed 
by the International Organization of Medical Physics (IOMP) for the day November 7th, in which it 
celebrates the anniversary of the birth of Marie Sklodowska-Curie. In this year IOMP proposes the theme 
"Looking into the Body: Advancement in Imaging through Medical Physics. 
 
 The Conference Program also includes two joint sessions with the event “Giornate di Studio sul 
Piano Triennale 2015-2017” of INFN (National Institute of Nuclear Physics). 
  
 
 We wish you a wonderful experience in this scientific event, and we also hope that you will be 
able to find time before or after the Conference to enjoy the many exciting experiences that the Trentino 
Province has to offer. 
 
Renzo Antolini Aldo Valentini 
Department of Physics Department of Health Physics 
University of Trento Azienda Provinciale per I Servizi Sanitari - APSS, Trento 
renzo.antolini@unitn.it aldo.valentini@apss.tn.it  
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Transport Oncophysics studies cancer as a proliferative disease of mass transport dysregulation at 
multiple scales, from the molecular to the cell-, tissue-, organ-, and organism-level.  
The fundamental characteristics of the mass transport differentials in cancer are associated with 
the pathological modifications of biological barriers that accompany carcinogenesis. Examples of these 
are the hyper-permeabilization of vascular endothelia; the  flow patterns in highly anastomotic angiogenic 
vasculature; stromal hypertrophy; and overexpression of ionic and molecular efflux pumps in tumor-
initiating and therapy-resistant cells.  
Employing methods of Transport Oncophysics it is not only possible to develop novel biomarkers 
of disease and therapeutic response, but also to envision novel modalities of treatment, especially in the 
context of metastatic disease, and with the use of therapeutic carriers optimally designed to address the 
mass transport challenges that pertain to cancer, and its pathological modification of biological barriers.  
In this presentation I will review the fundamentals of Transport Oncophysics, review some recent 
advances in its clinical application to cancer diagnostic and prognostics; and present some 
nanotechnology-based transport solutions and application in preclinical models of metastatic disease. 
 
Hitting genomic stability: from cancer cause to cancer cure. 
 
F. Pentimalli1 and A. Giordano1,2,3 
(1) Oncology Research Center of Mercogliano (CROM); Istituto Nazionale Per Lo Studio E La Cura Dei 
Tumori “Fondazione Giovanni Pascale”; IRCCS; Naples, Italy 
(2) Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy 
(3) Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of 
Science and Technology, Temple University, Philadelphia PA, USA 
 
The association between cancer and the environment dates back to the 18th century, long before the birth 
of modern epidemiology. Among the environmental factors associated with cancer, physical agents, X 
rays in particular, were early recognized as capable of increasing cancer rates, inducing tumors that 
developed at sites of irradiation [1]. Although not all carcinogens are mutagenic to DNA, many chemical 
and physical agents act directly or indirectly on DNA, challenging genome stability. Whereas ionizing 
radiations induce DNA double strand breaks, UV rays induce the formation of cyclobutane pyrimidine 
dimers (CPDs), highly mutagenic species that hamper the DNA replication process. 
The ability of many chemotherapy drugs and of ionizing radiations to damage the DNA of the highly 
proliferating cancer cells has been the mainstay of antitumoral treatments in the clinical setting. However, 
during the past decades we have moved from a one-size-fits-all approach, typical of cytotoxic 
chemotherapy, to a personalized medicine strategy that aims to develop molecularly targeted drugs able to 
exploit particular genetic addictions, dependencies and weaknesses of cancer cells. 
Unfortunately, however, cancer cells are highly heterogeneous at the molecular level and tumours 
continuously evolve managing to escape therapeutic treatments. The main cause of such heterogeneity is 
the underlying genomic instability, which has been recently defined as one of the key hallmarks enabling 
cancer development and progression [2]. Recently, many molecular mechanisms that drive the complex 
cell response to DNA damage have been identified, which, not only helped to shed light on the events 
triggering tumour development and progression, but also provided new targets for more specific 
anticancer therapeutic approaches, the best example being the use of PARP inhibitors for the treatment of 
breast and ovarian cancer owed to faulty BRCA genes, with PARP and BRCA both involved in DNA 
repair pathways [3]. In our lab we study the mechanisms that regulate cell cycle, which are strictly 
connected to the cell response to DNA damaging agents, and test new strategies that could function as 
synthetic lethal approaches to sensitize cancer cells to DNA damaging agents, including radiations and 
chemotherapy drugs [4,5]. 
 
References: 
[1] RA Weinberg. The biology of cancer. Garland SCIENCE, Taylor and Francis Group, LLC 2007. 
[2] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. Mar 4;144(5):646-74 
(2011).  
[3] Turner N, Tutt A, Ashworth A. Targeting the DNA repair defect of BRCA tumours. Curr Opin 
Pharmacol. Aug;5(4):388-93 (2005). 
[4] Indovina P, Marcelli E, Di Marzo D, Casini N, Forte IM, Giorgi F, Alfano L, Pentimalli F, Giordano 
A. Abrogating G2/M checkpoint through WEE1 inhibition in combination with chemotherapy as a 
promising therapeutic approach for mesothelioma. Cancer Biol Ther. 15(4):380-8 (2014).  
[5] Di Marzo D, Forte IM, Indovina P, Di Gennaro E, Rizzo V, Giorgi F, Mattioli E, Iannuzzi CA, 
Budillon A, Giordano A, Pentimalli F. Pharmacological targeting of p53 through RITA is an effective 
antitumoral strategy for malignant pleural mesothelioma. Cell Cycle 15;13(4):652-65 (2014).  
 
 
Perspectives in particle radiobiology 
Marco Durante 
 
Department of Biophysics – GSI Helmholtz Center – Darmstadt, Germany.  
Department of Condensed Matter Physics - University of Darmstadt – Darmstadt, Germany 
 
Radiotherapy is an essential tool for curing cancer. Over 50% of all 
patients with localized malignant tumors receive radiotherapy as part 
of their initial therapy, either alone or, more frequently, in 
combination with surgery and chemotherapy. Ionizing radiation 
effectively kills human cells, and sufficiently high doses of radiation 
can sterilize any tumor and achieve nearly 100% tumor control 
probability. However, in external-beam therapy healthy tissue is 
unavoidably exposed to radiation, therefore increasing the normal 
tissue complication probability. Over 90% of the patients worldwide 
are treated with high-energy X-rays produced by electrons 
accelerated to several MeV in linear accelerators (linacs). 
Controlling tumors non-invasively using high-energy charged 
particles (protons or carbon ions) offers advantages over 
conventional X-ray therapy, since a lower radiation dose is delivered 
to healthy tissues. Protons and heavy ions deposit energy far more 
selectively than X-rays, allowing a higher local control of the tumor, 
a lower probability of damage to healthy tissue, low risk of 
complications and the chance for a rapid recovery after therapy. 
Charged particles are also useful for treating tumors located in areas 
with radiosensitive surrounding tissues, such as the brain, spinal cord 
and kidney and in anatomical sites where surgical access is limited. 
Current trial outcomes indicate that accelerated ions may be capable 
of replacing surgery for radical cancer treatments, which may be 
beneficial as the success of surgical cancer treatments are largely 
dependent on the expertise and experience of the surgeon and the 
location of the tumor. However, only a small number of controlled 
trials to date have made comparisons between particle therapy and 
X-rays, making comparisons difficult. Research in medical physics 
and radiobiology is concentrating on reducing the costs and 
increasing the benefits of this treatment. 
Radiation biology is a potential breakthrough in radiotherapy. DNA 
damage induced by charged particles is quite distinct from the 
damage induced by X-rays, as it can be seen using markers of DNA 
damage (such as the histone γH2AX – see figure) and high-
resolution microscopy. We will present recent results showing that charged particles elicit a distinct 
dmage response signal cascade, which can be used for optimizing the treatment in combination with 
specific drugs. Particularly important are drugs targeting the DNA resection pathway and immunotherapy 
drugs, which enhance the immunogenic response caused by localized high doses of heavy ions. Physics 
and biology are entangled in particle therapy, and this interaction may lead to major breakthroughs in 
treatment of several lethal cancers. 
 
References: 
[1] J.S. Loeffler and M. Durante, Charged particle therapy--optimization, challenges and future directions. 
Nat Rev Clin Oncol. 2013;10:411-24. 
[2] M. Durante, N. Reppingen and K.D. Held, Immunologically augmented cancer treatment using 
modern radiotherapy. Trends Mol Med. 2013;19:565-82 
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Physical aspects in the evolving models of cancer treatment with radiations. 
 
 
Alessio G. Morganti (1, 4), Savino Cilla (2), Gabriella Macchia (1), Francesco Deodato (1), Milly 
Buwenge (1), Angelo Piermattei (3), Vincenzo Valentini (4). 
 
 
Radiotherapy Unit (1), Medical Physics Unit (2), Università Cattolica del S. Cuore, Campobasso, Italy; 
Medical Physics Department (3), Radiation Oncology Department (4), Università Cattolica del S. Cuore, 
Roma, Italy. 
 
 
 Radiation therapy is an important therapeutic resource in treating cancer. Over the past decades 
there has been a gradual evolution in the interpretation models of the effect of radiation. 
 
 Initially, particular attention was paid to the physical and chemical mechanisms underlying the 
DNA damage. This interest stimulated the research in the field of therapy with hadrons, in some cases 
with higher biological effectiveness, and a series of studies on the so-called “oxygen effect”, namely on 
the radioresistance of tissues (especially cancer) in the absence of O2. In fact, more and more evidences 
have identified chronic hypoxia as one of the main factors responsible for the lack of success of treatment 
with radiations. These studies have focused on the possible use of blood transfusions or erythropoietin for 
the treatment of anaemia and on the possible use of hyperbaric chambers. Another line of research 
focused on the time-effect, meaning both total duration and fractionation of radiotherapy. As part of this 
trend several trials on the use of accelerated (to increase the chance of cure) and hyperfractionated (to 
reduce the risk of late side effects) regimens can be included.  
 
 More recently, interest has shifted mainly on biological-genetic factors able to provide an 
interpretation of the radiotherapy antineoplastic effect and in particular of the radioresistance of cancer 
cells. This interest stimulated the search for genetic therapies capable of reversing radioresistance 
mechanisms in order to increase the probability of cure. At the same time, the introduction of the models 
of Tumor Control Probability (TCP) and Normal Tissues Complication Probability (NTCP) allowed to 
deepen the knowledge of the so-called “volume-effect”. This knowledge, in turn, allowed the testing of 
treatment techniques aimed at reducing the NTCP (especially in tissues with “parallel” functional 
organization), thanks to a reduction of the irradiated volume, and the increase of the TCP due to dose 
escalation. The result of these investigations is represented by the rapid acceleration in the evolution of 
treatment techniques, aimed at an increased dose conformation (conformal radiotherapy, intensity 
modulated radiotherapy, image guided radiotherapy, stereotactic radiotherapy or radiosurgery).  
 
 Even more recently, interest has shifted outside of the cellular environment and in particular to the 
"microenvironment" [1]. In fact, the extracellular space is considered today as the home of several 
phenomena related to the progression of cancer and to the anti-tumor effect of radiations. Together with 
the so-called "acute hypoxia", due to short increments of intratumoral pressure, it was observed that the 
same condition of hypoxia is able to change the plasticity of the extracellular matrix, promoting 
ultimately both tumor progression and the same hypoxia. Furthermore, it was observed that radiations are 
able to act on the same mechanisms stimulated by hypoxia, thus favouring phenomena such as radio-
induced tumor invasion and radiation-induced hypoxia (Figure 1). From these observations, new lines of 
research emerged aimed at identifying and inactivating several targets responsible for this somewhat 
paradoxical phenomenon. 
 
 In conclusion, the evolution of models addressing the antitumor effect of radiation allowed, over 
time, the definition of new therapeutic strategies for the treatment of cancer. 
 
 References 
 
1. Hanahan D, Weinberg RA, Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674. 
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100 years of Imaging in Radiotherapy – and what’s next? 
 
Frank Lohr, M.D. 
 
Dept. of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Germany 
 
Radiotherapy established itself as a significant tool in oncology surprisingly fast after the discovery of X-
rays. With an almost simultaneous inception, diagnostic and therapeutic radiology remained closely 
linked and in the same hands for the better part of the last century and only in the late 1980s the field 
divided into two specialties. 
 
Imaging related to radiotherapy is of supreme importance in two main areas:  
 
- Diagnostic radiological images provide essential information for target (tumor) identification, the 
assessment of tumor spread into neighbouring and distant tissues as well as providing information 
about localization and mobility of normal structures that have to be spared from therapeutic 
radiation doses. While planar X-ray imaging has fulfilled these functions in some situations, 
volume imaging based on Ultrasound, Computed Tomography (CT) and Magnetic Resonance 
Imaging (MRI) have dramatically changed the radiotherapy workflow. While initially only 
morphological information was provided even by cross-sectional/volume imaging, increasingly 
functional information can be obtained from both CT (with dual source CT as a fundamentally 
new modality) and MRI and, more recently and with a plethora of possibilities, Positron Emission 
Tomography (PET). Finally, quantification of tumor response with imaging provides more 
objective data than clinical exams, an absolute necessity within the framework of clinical trials.  
 
- Imaging innovations at the treatment device such as stereoscopic X-ray-imaging and particularly 
Cone Beam CT (CBCT) have dramatically increased patient and tumor positioning accuracy. Real 
time tumor tracking or fast image guided breathhold treatments have become clinically feasible 
and hold the potential to further improve clinical results.  
 
Despite all these advances, the development of imaging for and during radiotherapy has not lost its 
dynamics: 
 
- Online Imaging during treatment with Ultrasound and MRI is currently becoming a clinical reality 
providing 4D-imaing information during dose delivery. While established only for photon 
radiotherapy, it is a necessity to fully unlock the potential of radiotherapy with charged particles. 
Based on the constant refinement of detector technology, imaging modalities such as Cherenkov 
imaging that have been a theoretical possibility for decades are now becoming technically 
feasible.  
 
- In vivo imaging is venturing into dimensions closer to the cellular level. This will first provide 
further insight into tumor biology and systems biology in general (supremely important for 
immunological interventions) in animal models but will gradually also improve the imaging 
armamentarium in human subjects.  
Development of in-vivo imaging techniques for charged particle therapy 
G. Battistoni1 
 
(1) INFN, Sezione di Milano 
 
Purpose: Charged particle therapy (hadron therapy) is a highly advanced technique of cancer 
radiotherapy that uses beams of charged hadrons (protons or light ions) to destroy tumour cells. While 
conventional X-rays traverse the human body depositing radiation as they pass through, ions deliver most 
of their energy at one point. Hadron therapy is most advantageous once the position of the tumour is 
accurately known, so that healthy tissues can be protected. Accurate positioning is a crucial challenge for 
targeting moving organs, as in lung cancer, and for adapting the irradiation as the tumour shrinks with 
treatment. Therefore, quality assurance becomes one of the most relevant issues for an effective outcome 
of the cancer treatment. In order to improve the quality assurance tools for hadron therapy, the scientific 
community is studying specific imaging approaches for real-time non invasive monitoring, quantitative 
imaging and precise determination of delivered dose, fast feedback for optimal treatment planning and 
real-time response to moving organs. Some of recent results will be reviewed. 
 
Methods and materials: Several research institutions are active in research and development of imaging 
for particle therapy. The main activities concern Time-of-Flight In Beam PET, In-beam single particle 
tomography, in-vivo dosimetry for particle therapy and moving target volumes, combination of in-vivo 
dosimetry, treatment planning and Monte Carlo simulation of in-vivo dosimetry. 
In the last years, the topic received a boost in Europe also thanks to ENVISION (European NoVel 
Imaging Systems for ION therapy) project. funded by European Commission in the framework of the VII 
Framework Program for Research in the period 2010-2014.  
 
Results: Many have been the outcomes of these projects. At present, the main preferred directions remain 
the detection of annihilation photons from induced beta+ activity and prompt gamma imaging. This last 
solution received a particular attention within ENVISION project in terms of valorisation and 
development of industrial devices ready for clinical evaluation. New ideas are also emerging, although at 
a very early stage, like the proposal of detecting secondary charged particles. 
  
Conclusion: Many achievements have been obtained in recent years in the field of imaging of charged 
particle therapy. However more work is still needed to bring the proposed techniques to a mature level for 
clinical application. Centers for hadrontherapy and Physics research institutes are establishing 
cooperation agreement to test and develop prototypes and new approaches. 
 
References: 
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Purpose: In the last decades there has been a significant growth of the number of radiological 
examinations, resulting in an increase of radiation dose per capita. Multidetector computed tomography 
(MDCT) nowadays makes the largest contribution among X-ray imaging techniques to the collective dose 
of a population. Data from literature indicate that multiple imaging procedures are frequently performed, 
with patients receiving CT scans corresponding to an effective cumulative dose of tens of mSv. For this 
reason, it is important to reduce the radiation dose given to patients in every MDCT examination without 
impairing its diagnostic quality, following the strict guidelines contained in the new European Directive 
2013/59/EURATOM of 5 December 2013, that gives challenging targets to all stakeholders in terms of 
justification, optimization and patient information. 
Methods and materials: Despite the evidence that MDCT provides invaluable information for diagnosis 
and patient management, the cancer risk associated with the radiation dose in MDCT is not zero and it is 
clear that reducing radiation dose must continue to be one of the top challenges in radiology. There are 
some technical strategies that are commonly used for radiation dose reduction in MDTC. One common 
method is to adjust the x-ray tube current using the Automatic Exposure Control (AEC), which aims to 
automatically modulate the tube current to accommodate differences in attenuation due to patient 
anatomy, shape and size. The tube current may be modulated as a function of projection angle (angular 
modulation), longitudinal location along the patients (z-modulation) or both. It is also possible to 
minimize radiation dose by using lower tube potentials (kV) in MDCT imaging.  
Recently, iterative reconstruction has introduced relevant changes in the practice of MDCT. In 
comparison with the conventional filtered back projection techniques, by using iterative reconstruction 
the number of projection views can be significantly reduced without sacrificing image quality. Therefore, 
iterative reconstruction algorithms have significant potential to reduce radiation dose in MDCT.  
In the last few years, there is also wide interest in patient exposure tracking. Constant and systematic 
monitoring of radiation dose is indispensable in order to increase the quality of radiological services. 
Radiation exposure tracking can be either for an individual patient or for quality assurance and 
benchmarking purposes. Many vendors already provide means to track patient exposure history with new 
software tools that can automatically retrieve, store and analyze dosimetric data stored in a Picture 
Archiving and Communication System (PACS). This activity can lead to performance control, protocol 
optimization and rapid correction of wrong practices. The principal aim of the dose tracking is to 
minimize the dose variability in radiological procedures, which is clinically not justified. 
 
Results: New technologies for dose reduction and patient exposure tracking are crucial elements in order 
to reduce radiation dose in diagnostic radiology and to improve the radiologic quality management.   
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PET/CT and molecular imaging 
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Radionuclide imaging is the most popular form of imaging used for oncological molecular imaging (MI). 
MI can be broadly defined as in vivo characterization and measurement of biologic processes at the 
cellular and molecular level. Molecular imaging techniques such as PET (positron emission tomography) 
have been introduced in the clinical practice to study the molecular pathophysiology and to assess 
treatment responses.  Molecular imaging rapidly developed in the early 90’s, due to parallel evolution and 
integration of many different disciplines, including medical imaging, molecular biology, pharmacology, 
and medical physics.  
 
PET is a functional imaging technique of Nuclear Medicine that produces 3d images allowing the 
visualization and quantification of complex pathophysiological and biochemical processes presenting in a 
living system [1]. PET uses specific radionuclides labelled to molecular probes in order to generate in 
vivo images of physiological processes but also to identify and characterize many kind of disease, 
including cancer, endocrine, gastrointestinal, neurological disorders, heart disease, infections and 
inflammatory disease that could be anticipated of macroscopically evident changes. PET can also be an 
ideal tool for the development of new drugs, by characterizing their behaviour in the human body, acting 
as a bridge between preclinical and clinical research.  
Combination of PET with CT or MRI provides the capability of acquiring simultaneously anatomical and 
functional images for any part of the human body. Modern PET/CT scanners integrate high-end multi-
detector-row CT scanners with Time-of-Flight (TOF) PET scanners[2]. 
 
The tracer most widely used in PET imaging is 18F-Fluorodeoxyglucose (FDG), that has indeed 
revolutionized the imaging evaluation of patients with tumour and has been used for about 25 years, with 
more than 1.5 millions scans performed annually worldwide. FDG, a glucose analogue, becomes trapped 
in the human cells after injection, through uptake and phosphorylation: FDG-PET resulted a specific, 
sensitive and reproducible imaging techniques for studying cancer. [3] 
 
18F-FDG was originally proposed in the 70’s for basic investigations of cerebral glucose metabolic rate 
and thereafter it was discovered useful for cancer imaging [4]. The link between glucose metabolism and 
tumoral cells derived from Nobel prize laureate, Otto Warburg who hypothesized that glucose metabolism 
would increase in the tissues affected by cancer in correlation with the malignancy. Tumour hypoxia 
could switch the metabolic pathway to glycolysis from oxidative phosphorylation, and glycolysis 
guarantees cancer cells growth with a faster energy production. This aspect remains, today, a major 
indicators of tumour proliferation [5-6-7]. 
 
PET radionuclides are unstable nuclides that decay by the emission of a positron. The subsequent 
annihilation produces two anti-parallel gamma photons, both with energy of 511 keV. PET scanner detects 
the coincidence of these gamma photons. PET radiopharmaceuticals are usually administered, before the 
scanning procedure, as bolus in vivo injections; generally there is a delay before scanning to allow the 
tracer to accumulate in the target. [8] 
 
Limitation of FDG-PET for cancer imaging include: 
 Limited reconstructed spatial resolution (about 4-5 mm in recent scanners), subsequently a 
negative scan cannot exclude the existence of a very small cancer;  
 Some tumours (such as mucinous carcinomas) may have a low FDG uptake and may not be 
detected using such tracer; 
 Inflammation and other conditions can show moderate or high glucose uptake. Discriminate 
cancer from inflammation/other conditions could sometime be difficult [8-9] 
 In the recent years various other tracers (non-FDG) have been developed and used in PET molecular 
imaging. An example of a cancer specific, non-FDG, PET tracer is the carbon-11 labelled form of Choline 
(11C-Choline), a precursors for the synthesis of phospholipids that can marking out membrane 
metabolism. The clinical value of 11C-Choline is relevant in prostate cancer relapse in previously treated 
patients [10]. 
11C-Methionine is an other example of tracer useful to evaluate protein metabolism, significantly 
increased in malignant tumour, especially in brain (main clinical application) and head and neck tumours 
[11]. 18F-Dihydroxyphenylalanine (18F-DOPA) [12], originally introduced for studying of movement 
disorders, was successfully used in the study of neuroendocrine tumours (NET). 
68Ga-DOTA-peptides (such as TOC and NOC) take advantage from overexpression of somatostatin 
receptors in NET, are therefore are excellent tracers in the evaluation of NET, either for staging, and other 
clinical applications [13-14]. 
18F-fluorothymidine (18F-FLT) is a marker of cellular proliferation and correlates with DNA synthesis 
and cellular growth. 18F-FLT has been suggested in several malignancies, such as lymphomas, sarcomas, 
lung or gastrointestinal tumours [15]. 
The list of new potential PET tracers is continuously increasing and new applications of PET/CT are 
rapidly growing, in the study of cancer and other disease: they are likely to be introduced in the clinical 
practice in the next future. 
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Cracking the neural code using tools and concepts from statistical physics 
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In this talk, I will give an overview of our research line that uses some of the concepts from statistical 
physics (such as entropy and mutual information) to crack the code used by neurons in the cerebral cortex 
to transmit and exchange information about important events in the sensory world.    
Functional Imaging of the Human Brain using MEG and fMRI 
Gian Luca Romani1,2 
 
(1) Department of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University, Chieti; 
(2) Institute for Advanced Biomedical Technologies (ITAB), "G. D'Annunzio" University, Chieti. 
 
Purpose: the use of non invasive techniques such as functional Magnetic Resonance Imaging (fMRI) or 
MagnetoEncephaloGraphy (MEG) permits powerful investigation of brain functions, specifically 
providing an accurate identification of active areas as well as a precise description of the timing of brain 
response. Recently, a combined approach of both modalities and successive integration of the results has 
proved to be extremely useful for the understanding of more complex mechanisms, namely "resting state 
networks", that have been supposed to likely account for a large part of the basic energy consumption of 
the brain. In this presentation some basic concepts of the two methodologies will be briefly described 
with the aim at pointing out respective advantages and limitations and the possible benefits provided by 
their integration. Then some recent results obtained applying the two techniques in basic neuroscience 
will be illustrated. 
Methods and materials: fMRI, uses the Blood-Oxygen-Level-Dependent (BOLD) contrast method to 
identify - with high spatial resolution - neural pools where the energy consumption has increased during 
sensory stimulation or execution of a task. However, since this technique relies on the hemodynamic 
response, its temporal resolution is in general of the order of 1s. On the other hand, MEG measures the 
tiny electric fields associated with bioelectric activity of groups of neurons and, with respect to 
ElectroEncephaloGraphy (EEG), offers the important advantage of permitting identification of the actual 
sources of the signals with no- or minimum interference by the medium surrounding the sources 
themselves. However, the unavoidable need of solving the inverse problem reduces the spatial resolution 
to a few mm at the best and only in the case of sharply localized sources. Additionally, the extreme 
weakness of signals requires the use of superconducting magnetometers, namely SQUIDs, and that of a 
magnetically shielded room to perform the measurement. Since the recording bandwidth of these devices 
is relatively large, it is possible to record neural activity with a time resolution of 1ms or less. This makes 
MEG technique the ideal complement of  fMRI to track brain activity in time and space. 
Results: two examples will be provided. The first will illustrate how integration between fMRI and MEG 
permits to follow neural current density distribution during a time span of about 500ms, as a consequence 
of a picture-naming test. The second will show how Resting State Networks (RSNs) are identified using 
fMRI and MEG and the different kind of information that can be obtained with the two approaches. In 
particular the dynamic activity of RSNs, as measured by MEG only, will be shown, as a result of 
analyzing in specific bandwidths the spontaneous activity of the brain. 
Conclusions: fMRI and MEG represent two unique tools to 
investigate brain activity. Their combined approach is proving 
to provide a synergic effect, in simple source identification, in 
understanding of hierarchical processing of information, and in 
the investigation of the dynamic correlation between different 
brain RSNs that - with their relation to spontaneous activity - 
likely account for a large  part of energy consumption in the 
brain. 
 
Modified from de Pasquale et al., PNAS 2010. 
 
 Diffusion Tensor Imaging and modern neurosurgery: toward a connectomic approach to brain 
surgery. 
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38122 Trento, Italy 
 
Purpose Technical and methodological advancements in physics provided new insights in neurosciences 
and neurosurgery. Particularly, introduction and improvements in diffusion tensor imaging (DTI) opened 
a new door in the study of human white matter (WM)[1]. The fascinating tractographic reconstructions 
renewed the interest for structural connectivity and its role in the models of organization of brain 
functions, moving on the connectome era[2]. Every brain function is the result of complex and large-scale 
integrations of multimodal analyses, subserved by parallel and distributed networks connected by 
different long and short bundles. Even if highly sensitive and continuously improved, the DTI has 
different technical limitations. It produced a renewed interest for WM anatomical dissection and these 
data were extensively integrated[3,4]. However, both these techniques do not provide functional 
informations. Direct electrical stimulation (DES) during awake surgery for cerebral gliomas is a unique 
opportunity and a validated technique to obtain on-line and reliable functional informations regarding the 
subcortical connectivity. The challenge is now the integration of functional and structural data in order to 
understand the role of the different bundles and the anatomical connections subserving the different 
networks.  
Materials and Methods For DTI we adopted a 60 directions diffusion-weighted imaging brain 
tractography with 1.5-T MRI scanner (GE Healthcare, UK) and an eight-channel head coil. It is 
performed using a single-shot multislice spin echo–echo planar sequence with the following attributes: 40 
slices; slice thickness: 2.4 mm; matrix 256 x 256; TR: 10,000; TE: 92,7; flip angle: 90. Pre-processing, 
diffusion tensor calculation and tracking are performed with FMRIB Software Library (FSL; 
http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/), Diffusion Toolkit and TrackVis (http://trackvis.org), respectively. 
Specimens for dissection were fixed in a formalin 10% solution and then frozen at -80° C. Intraoperative 
DES during asleep-awake-asleep surgery for resection of brain tumors provided the functional data. All 
patients underwent to extensive pre-operative neuropsychological assessments integrated with DTI 
imaging. 
Results DTI reconstructions of the peri-sylvian WM showed two main streams. A dorsal pathway 
composed of three main bundles: the anterior and posterior indirect components of the superior 
longitudinal fascicle (SLF) and the arcuate fascicle (AF). The dissection confirmed these data 
demonstrating terminations of the indirect anterior SLF within the ventral pre-motor cortex (VPMC) and 
posterior third of the middle frontal gyrus (MFG). The AF directly connects the VPMC, the pars 
opercularis and the MFG to the posterior thirds of the superior and middle temporal gyri and the middle 
third of the inferior temporal gyrus. The DES demonstrated the role of the AF as the main phonological 
stream. The indirect anterior SLF is involved in the articulatory loop for language production. The 
indirect posterior portion was proposed as a possible semantic retrieval bundle. AF and the anterior and 
posterior indirect components of the SLF constitute the most long associative bundles of the lateral white 
matter of the frontal, temporal and parietal lobe and provide a horizontal connection between the main 
language territories. The inferior-fronto-occipital fascicle (IFOF) constitutes the ventral pathway. Recent 
dissection evidences demonstrated new terminations of IFOF within the parietal lobe and a deeper and 
more ventral component directed to the dorso-lateral pre-frontal cortex. DTI confirmed these structural 
data and DES supported the role of this tract in the semantic network. 
Conclusions DTI and recent advancements in brain imaging encouraged and supported the structural and 
functional study of the human WM from both a conceptual a practical point of view. Tractography joined 
the clinical practice and it is now a valid and reliable tool for surgical treatment of lesions harboring 
eloquent regions. The integration of DTI with structural data of dissections and with functional evidences 
of DES improved our comprehension of brain networks organization. 
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Purpose: Some kind of hepatocarcinomas (HCC) can be treated with a recent radiotherapy technique: 
hepatic radioembolization (TARE). In order to increase the treatment efficacy, an improvement of the 3D 
dose calculation methods is crucial, for both neoplastic and healthy tissues. The aim of this work is to 
estimate the α radiobiological parameter of the linear quadratic model in order to perform a personalized 
calculation of the activity to be injected to the patient. 
 
Material and Methods: The radioembolization involves an activity administration, through an intra-
arterial  injection of biocompatible microspheres 90Y loaded. 90Y is mainly a β- emitter, therefore the 
electron short range is suitable to release high dose to a small region of neoplastic tissue. The 
radionuclide spatial distribution is not uniform, for this reason a 3D dose calculation is needed. For this 
calculation CT-SPECT images, obtained injecting the patient before the treatment with Technetium 
99mTc albumin aggregated (99mTc-MAA) in the same site where microspheres are going to be injected, 
were used to obtain the activity distribution, this procedure makes sense assuming that 99mTc-MAA 
behave as microspheres. The counts obtained are assumed to be proportional to the dose for each voxel, 
with a proportionality constant calculated as described in [1]. After the treatment the evaluation of the cell 
survival fraction was performed by using the linear quadratic (LQ) model, which is the radiobiological 
reference model in radiotherapy. The main parameter of this model, in linear approximation, is α which 
describes the radiobiological response to a deterministic fatal damage due to ionizing radiations. In order 
to estimate α, a group of 16 patients (3 cholangiocarcinoma and 13 HCC) was followed after the 
treatment for a period of time up to 9 months: the mass of the tumor was measured every 3 months and 
the minimum value was considered; the voxel-by-voxel formulation of the  LQ model was employed with 
the 3D dose and the final mass. 
 
Results: The value obtained for α is 0.22 ± 0.22 Gy-1 and 0.20 ± 0.23 Gy-1 for HCC and 
cholangiocarcinoma patients respectively. These values are the mean and the standard deviation of the 
values calculated for each patient and agree with the order of magnitude of the same parameter proposed 
by AAPM [2]. 
 
Conclusions: The hepatic radioembolization with  90Y microspheres is a recent and promising technique. 
The estimate of the α radiobiological parameter is crucial for the personalized calculation of the activity 
to be injected, which is fundamental for improving the efficacy of the treatment. 
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Purpose: Thermoluminescence dosimetry is one of the most widely used and cheap techniques of 
radiation dosimetry. Thermoluminescence dosimeters (TLD) features many advantages such as small 
detector size and close tissue equivalence that make it useful for application in radiotherapy in vivo 
dosimetry. Due to their small size, TLDs are convenient for point dose measurements in phantoms as well 
as for in vivo dosimetry on patients during radiotherapy treatment [1]. The response of TLDs is energy 
and dose-per-pulse rate dependent. Intra Operative Radiation Therapy (IORT) is a treatment modality 
where a large single radiation dose is delivered during a surgery, either with or without a resection of a 
neoplastic mass. Accelerators specifically designed for IORT are characterized by dose-per-pulse rate 
(about 3–12cGy/pulse) several times higher than conventional accelerators (0.1–0.6cGy/pulse) [2]. The 
behaviour of TLD dosimeters when irradiated by high dose-per-pulse beam was not been fully 
investigated. In the present study, a characterization of TLD’s response to high dose-per-pulse electron 
beam from an IORT device was carried out. 
 
Methods and materials: Of the many types of TLDs available, the lithium fluoride doped with 
magnesium and titanium LiF:Mg,Ti (TLD-100) is the most widely used dosimeters in routine personal 
dosimetry, environmental monitoring and space dosimetry. This popularity is due to its approximate tissue 
equivalence (effective atomic number of 8.2, similar to 7.4 for tissue) which is an important factor in 
personal dosimetry and in medical application, low signal fading (5 - 10% per year), wide linear response 
range and high sensitivity for very low dose measurements. In particular, it is known that the 
thermoluminescence response of TLD-100 at conventional radiotherapy photon beams is linear for doses 
<10 Gy [3]. Forty-five TLD-100 (Harshaw Chemical Company) chips with nominal dimensions of 3.2 × 
3.2 × 0.89 mm were irradiated with an electron beam produced by an IORT specific accelerator (nominal 
energy 9MeV). The dose dependence of TLD-100 was studied in the range 0-10 Gy, i.e. the range of 
interest in IORT technique. Regression analyses was performed to establish the response variation of 
thermoluminescence signal with dose and energy.  
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Statistical analysis: For each point of measurements (0-10 Gy in step of 2 Gy) the mean and standard 
error of the response of 9 TLD’s was calculated. A linear and a no-linear (quadratic) regression was 
performed between TLD response and doses; the goodness of the fit was evaluated by the R2 coefficient. 
The better performance of the two models was assessed by F test. 
 
Results: The linear model has an R2= 0.994 while the quadratic model has an R2 = 0.999. The result of F 
test was approving the quadratic model (p<0.0045). 
 
Conclusion: The thermoluminescence response of TLD-100 is energy and dose-per-pulse rate dependent: 
when irradiated with a conventional radiotherapy photon beams this response is linear for low doses. In 
this preliminary work we found that to describe the dependence of thermoluminescent signal of TLD with 
the absorbed dose when irradiated by a IORT dedicated accelerator a quadratic model performs better 
than a linear model. 
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Purpose: Medical imaging with ionizing radiation is the non-invasive technique most widely used to 
identify internal injuries and lesions and effective doses given in a single medical imaging exposure are 
universally within the low-dose range (<100 mSv). Risks associated to ionizing radiation from medical 
imaging techniques have focused the attention of medical society and general population and some recent 
epidemiological studies showed an increased incidence of cancer in patients who underwent to 
radiological examinations [1]. Therefore, it is necessary to balance the benefit/detriment relationship of 
such examinations in order to establish the conditions under which its use is justified. Constant and 
systematic monitoring of radiation dose is indispensable in order to increase the quality of radiological 
services to patients. 
Methods and materials: The purpose of dose tracking is to strengthen the process of justification and 
optimization with the intent to achieve better protection of patient [2]. Constant and systematic 
monitoring of radiation dose is indispensable in order to reduce the dose given to patients in every 
examination without impairing its diagnostic quality, according to the ALARA (As Low As Reasonably 
Achievable) principle. Dose monitoring can lead to performance control, protocol optimization and rapid 
correction of wrong practices. Lawmakers are interested in monitoring and reducing radiation doses, as 
shown by the newly published European Directive EURATOM/59/2013 that contains more stringent 
radiation protection rules, especially concerning patients’ protection. In particular, the European Directive 
requires that patients are informed about the risk associated with ionizing radiation, and that detailed 
information about radiation dose is included in every procedure's report. EU Member States must 
transpose the requirements of this Directive in their national laws by 6th February 2018. 
In the last few years, most vendors already provide means to track patient exposure history with new 
software tools that can automatically retrieve, store and analyze dosimetric data stored in a Picture 
Archiving and Communication System (PACS). These software can be installed on hospital networks, 
and are in most cases web-based, ensuring easy access to all authorized users.  
In Pisa University Hospital we established a multidisciplinary dose team composed of radiologists, 
technologists, engineers and physicists, and recently started to evaluate some commercially available dose 
management systems. Thanks to dose monitoring software, our dose team recovered and analyzed from 
1st January 2014 up to now more than 130,000 TC scans, about 7,000 mammography procedures and 
nearly 123,000 traditional radiography exams. Our analysis showed relevant dosimetric differences 
between examinations performed on similarly-sized patients and auditing, training and protocol 
optimization were used to ensure a better homogeneity of dosimetric values. The principal aim of the dose 
team is to minimize the variability which is clinically not justified. 
 
Results: Dose monitoring software represents an essential part of radiologic quality management by 
allowing the systematic control of dose performances, by contributing to the reduction of wrong practices, 
and by supporting protocol optimization.   
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Purpose: Preclinical studies are critical steps in the medical research process. Small animal external beam 
irradiation is one of the delicate fields in which the different anatomical scale impact the most and the 
technique may do the difference. For those centers in which both preclinical and clinical researches are 
conducted, the possibility of exploiting clinical devices for preclinical purposes may be of economical 
and scientific interest, besides a technical challenge. Small subcutaneous volumes coverage and short 
irradiation times are the main demands. In the present work the feasibility of using TomoTherapy for 
preclinical irradiation and the optimal setup have been analyzed. 
Methods and materials: Six groups of immunocompromized NOD SCID Xenografts have been 
irradiated during the period February-June 2014; mice were anesthetized and placed in a Plexiglas cage 
pie (2BiologicalInstruments). All of the irradiated mice were subcutaneously inoculated with human 
xenograft glioblastoma multiforme cells. 
High-resolution CT scans were acquired and reconstructed with a slice thickness equal to 3 mm for 
treatment planning purposes. Gross Tumor Volume (GTV) was delineated in between the low-abdomen 
region and the upper leg, where tumor cells were implanted. A Planning Target Volume (PTV) margin of 
2 mm was used. In order to confirm the location of the tumor, lead markers were applied on the skin of 
the mice. Prescribed total dose to lesions was 6 Gy in 3 fractions delivered with 6 MV TomoTherapy Hi-
Art and TomoTherapy HD (Accuray, Inc., Sunnyvale, CA). The two systems do not differ substantially in  
hardware or software implementations.  
TomoDirect Intensity Modulated Radiation Therapy (TD-IMRT) technique was applied with gantry fixed 
at 0° and 180°. Field width and Pitch were settled equal to 1.05 cm and 0.1. 
During 3 irradiations, in order to obtain a better coverage, a bolus layer has been placed upon mice's body 
to deposit radiation also in the superficial layer. The mean number of mice per cage pie irradiated without 
bolus (WOB) and with bolus (WB) were 5 and 7, respectively, for a total amount of 15 mice irradiated 
WOB and 20 mice irradiated WB. Treatment planning and dosimetric results of the two setups have been 
compared in order to determine the importance of this espedient. 
Before the delivery of each RT fraction, a MegaVoltage Computed Tomography (MVCT) image has been 
acquired in order to correct irradiation setup. 
Results: The average body volume of a single irradiated mouse was (19±2) cm3 and PTV volume was 
(5±4) cm3 and (2±1) cm3 for WOB and WB, respectively. On average, the total delivery time was 
(377±22) s and (360±27) s for WOB and WB, respectively. In particular, the average time of irradiation of 
a single mouse (total time/number of mice) was 75 s and 54 s, for WOB and WB, respectively. The 
average modulation factors (MFs) used for the optimization were 2 for WOB and 1.5 for WB. 
The average dose to PTV was 6 Gy for both groups with a maximum dose to the target equal to 6.7 Gy 
(112%) for WOB and 6.4 Gy (107%) for WB. 
Discussion and Conclusions: the good PTV coverage results show that it is possible to irradiate small 
animals by using Tomotherapy. Moreover, by adopting specific expedients it is possible to reduce 
irradiation time while achieving equivalent PTV coverage and higher dose homogeneity. Nevertheless, 
the time which can be dedicated to preclinical studies is limited by patients' treatments and clinical 
imaging devices do not allow a precise contouring of the target nor of the OARs. 
Tomotherapy systems may be a useful mean for small animals irradiation. Nevertheless, clinical-to-
preclinical adaptation is not easy to implement and further work is needed. 
Preclinical results are still under investigation. 
Acknowledgments: The present work was financially supported by the Italian 5 per Mille, 2008 
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Introduction: Multiple Sclerosis (MS) is a chronic demyelinating disease of the central nervous system. 
During the last years functional Magnetic Resonance Imaging (fMRI) studies have shown that cortical 
reorganization consistently occurs both in acute and clinically stable MS patients [1].  
Experimental Autoimmune Encephalomyelitis (EAE)  is considered a good model of MS both in rodents 
and non-human primates. In the present work we have investigated through fMRI and Voxel-Based-
Morphometry (VBM) the functional and morphological alteration in rats with induced chronic EAE. 
 
Materials and Methods:  EAE was induced as described in the literature [2].  Rats were investigated 
prior to EAE induction, 30 and 60 days post induction (dpi). To increase the sensitivity of the fMRI 
experiment, a SPIO contrast agent was administered. Electrical stimulation was delivered through needle 
electrodes inserted in the right forepaw. T2 weighted RARE images, acquired at high resolution, were 
analysed by VBM in order to investigate voxel-wise differences in local Grey Matter (GM) volume. 
 
Results: In healthy DA rats, fMRI revealed that 
most of the activated volume (AV) was observed in 
the controlateral hemisphere and specifically in the 
S1 cortex with a relevant percentage in the motor 
cortex (fig.1A). On 30 and 60 dpi, the activation 
pattern was substantially altered compared to the 
pre-induction stage and heterogeneous among 
different EAE rats. Activation was also detected in 
the ipsilateral right cortex and in some extra-cortical 
areas (Fig.1B-C). The qualitative comparison of 
fMRI maps showed an increased AV after EAE 
induction in all investigated rats. The total AV 
increased by about 80% (p<0.01) on 60 dpi vs. 30 
dpi. The Laterality Index (LI) is an index of 
hemispheric dominance in functional response. In 
our MS model, LI strongly decreased on 30 dpi 
(0.02± 0.16) compared to the pre-induction value 
(0.97±0.09) (p<0.05) while on 60 dpi it showed a 
tendency toward recovery (0.12 ± 0.19) remaining 
definitely lower than in healthy animals. Statistical 
maps (p<0.01) relative to VBM analysis showed a 
widespread reduction of GM volume in the cortex at 
30 dpi vs. pre-induction stage. This further 
progressed at 60 dpi. A statistical significant 
decrease (p<0.01) of the whole brain GM volume was found at 30 dpi (818.3 mm3 ± 4.6) and 60 dpi 
(816.8 mm3 ± 2.5) vs. pre-induction stage (850.2 mm3 ± 4.3). 
 
Conclusion: The present work is the first attempt to define a reliable model to dissect brain plasticity 
phenomenon occurring in MS patients. Such a tool could also be used as a sensitive indicator of 
therapeutic intervention in preclinical studies. This work was supported by Fondazione Italiana Sclerosi 
Multipla (FISM), grant support (FISM 10/12/F14 /2011). 
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Introduction: Magnetic Fluid Hyperthermia (MFH) involves the use of iron-based magnetic 
nanoparticles injected into the tumor mass [1, 2] to selectively heat malignant tissues. In 1963 the Italian 
scientist Salvatore Bellini reported the first description of magnetotactic bacteria (MTB), which naturally 
produce iron-nanoparticles named magnetosomes (MNs). Recently it has been reported that 
magnetosomes extracted from bacteria could have a new potential role in cancer treatment of MNs as 
“theranostics” agents [3,4,5]. 
Material and Methods: Magnetosomes were 
extracted from a bacterial strain, Magnetospirillum 
griphiswaldense. In vivo studies were performed on 
subcutaneous tumors obtained by injecting Human 
Glioblastoma cells (U87 MG) in mice. MNs (1.5 mg) 
were injected in the tumor tissue. Animals treated with 
MNs were exposed three times in a week for 20 
minutes to an alternating magnetic field (AMF) with 
23 mT strenght and 110 kHz frequency. The 
efficacy of the treatment was assessed measuring tumor 
volumes in vivo by magnetic resonance imaging 
(MRI) (Figure 2) and ex vivo by histology.  MRI was 
used to map the injection site and distribution of MNs 
in the neoplastic mass.  
Results: Transmission Electron Microscopy (TEM) 
shows the cuboctahedral structure of magnetosomes and 
their organization in chains (Figure 1a-c). 
Alterations in signal intensity of tumor tissues were visible in MRI images due to the presence of iron 
nanoparticles (Figure2). At histological examination, tumors treated with MNs and AMF were 
characterized by degenerating unclustered cells intruded by extracellular matrix with evidence of 
edematous and necrotic phenomena. A mild inhibition of the tumor growth was observed in animals 
treated with MNs and exposed to AMF, compared to controls. In a small number of animals an almost 
complete reduction of tumor mass was observed soon after MFH treatment. 
Conclusion: Magnetic Fluid Hyperthermia mediated by iron-based nanoparticles naturally produced by 
magnetotactic bacteria has been applied in an experimental model of glioblastoma. Although preliminary, 
our results show a mild inhibition of tumor growth.  In addition, our results demonstrate that MRI detects 
both the injection site of MNs and the dynamics of tumor size evolution. Theranostic is a combination of 
diagnosis and therapy; although further investigations are necessary, our data confirms that MNs exhibit 
some core characteristics of the so called “theranostic agents”. 
References: 
[1] Johannsen M, Eur. Urol. 52(6):1653-61( 2007) 
[2] Jordan A, J. Neurooncol 78: 7-14 (2006) 
[3] Alphandery E, Int. J. Pharm 434: 444-452 (2012) 
[4] Alphandery E, ACS Nano 23;5(8):6279-96 (2011) 
[5] Mannucci S et al, PLoSOne e108959 (2014) 
Figure 1: a shows the organization of MNs in chains in the bacteria 
(scale bar, 500 nm). Panels b-c show that the typical conformation of 
chains is maintained after isolation of MNs. Scale bars: b > 200 nm, 
c >100nm 
Figure 2: MRI animal treated with MNs injection with AMF images 
acquired before MNs injection (a), 24 h (b), one week (c) and two 
weeks (d) after MNs injection.  
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Purpose: The feasibility of a noninvasive analysis of human skin tissue samples with nonlinear 
microscopy techniques, like two-photon-excited autofluorescence and second harmonic generation 
imaging, was evaluated in a preclinical study. Central points were the resolution of subcellular structures 
allowing for a noninvasive tumor diagnostics and the extension of the maximum imaging depth by power 
compensation without inducing tissue damage. 
 
Methods and materials: Fixed biopsy tissue samples (healthy skin 
and neoplastic lesions) were used to study optical parameters which 
could allow to identify malignant lesions.  
Results were compared with subsequent histological analysis. 
Different exposure protocols were applied to test possible 
photodamage mechanisms induced by femtosecond laser radiation 
and their dependency on laser power, imaging depth, and number of 
exposures. 
 
Results: Combining autofluorescence and second harmonic 
generation data allowed  to discriminate subcellular structures and 
their distribution within skin layers [1]. Different damage 
mechanisms like photobleaching, photoionization, and 
thermomechanical damage were characterized, and depth and power 
limits could be determined.  
Based on these limits a damage-free power compensation scheme 
was defined, allowing for deep tissue optical biopsies [2].   
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The use of pattern classification methods is taking place as alternative approach to standard univariate 
analyses of structural brain Magnetic Resonance Imaging (sMRI) data. The machine learning technique 
has the advantage of intrinsically taking into account inter-regional correlations and it allows exploring 
the predictive power of sMRI. Despite these methods are potentially suitable to infer a large variety of 
neurological and neuropsychiatric disorders, in the present study we have implemented Support Vector 
Machines (SVM) to detect structural brain alterations in children with Autism Spectrum Disorder (ASD), 
a widespread neurodevelopmental disorder whose relevant impact on the neuroanatomy is still poorly 
investigated. 
The sMRI data of 41 male children (2-6 years, 21 ASD matched to 20 control subjects for age and Non-
Verbal Intelligence Quotient (NVIQ)) were preprocessed according to two different analysis protocols to 
finally extract brain features at different spatial scales. In the first place, the standard voxel-based 
morphometry (VBM) image preprocessing using SPM8 package was applied to analyze images and to 
extract whole-brain features (gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF) 
segmented tissue volumes) and GM voxel-based features. In the second place, the Freesurfer image 
analysis suite version 5.1.0 was used to obtain Region-of-Interest (ROI)-based features. It allows the 
cortical parcellation of each sMRI scan in 62 structures, according to the Desikan-Killiany-Tourville 
(DTK) atlas and it computes five surface based features for each DTK structure. To investigate which are 
the most relevant brain features to distinguish ASD from control subjects, we classified the three different 
sets according to the classification protocol based on linear kernel Support Vector Machine (SVM) 
classifiers. The classification capability of SVM is evaluated in terms of the Receiver Operating 
Characteristic (ROC) curve, computing the global performance index of the area under the ROC curve. 
The leave-pair-out cross-validation protocol has been adopted to reach the classifier performance without 
undesired bias, and the nested cross-validation was implemented to optimize free model parameters. The 
most discriminant brain regions in a case-control study have been visualized in discrimination maps with 
statistical significance (p<0.05) obtained through permutation tests. 
The relevance of ASD features in a binary discrimination problem emerges at the intermediate scale of 
GM subregions. The best classification performance is achieved in the classification of regional features, 
reaching the AUC of 74%. This value is enhanced to 80% when considering only subjects without 
developmental delay (NVIQ ≥ 70). By contrast, when the number of features becomes large with respect 
to the number of training cases (voxels-based features) or too poor (whole brain features), the classifiers 
lack sufficient power. The discrimination maps resulting from the permutation tests implemented at voxel 
and at ROI levels identify cortical regions that belong mainly to frontal, temporal and parietal lobes.  
In conclusion, the application of the machine learning technique to sMRI data leaded to highlight the 
salient features in the ASD-control classification tasks and to identify abnormalities in the neuroanatomy 
of young ASD children consistently at voxel and at ROI dimensional scales. The morphological 
abnormalities detected in this analysis involve the cortical networks linked to the common deficits of 
ASD subjects. 
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Purpose: This work presents a new semi-automatic tool for 3D segmentation, quantification and 
visualization of cardiac left atrium fibrosis, based on two type of image data: late gadolinium 
enhancement magnetic resonance imaging (LGE-MRI) images and magnetic resonance angiography 
(MRA) images. A comparison with the quantification and 3D visualization obtained from 3D bipolar 
voltage maps, the clinical reference standard technique for atrial substrate characterization was reported. 
The aim is to develop a non-invasive, semi-automatic and robust 3D segmentation, quantification and 
visualization of LA fibrosis tool, allowing fast availability, accuracy of results and possibility to stratify 
patients with atrial fibrillation (AF) that are candidates for radiofrequency catheter ablation (RFCA). 
Methods and materials: In this study 10 consecutive patients suffering AF with different grades of atrial 
fibrosis candidates for RFCA were considered at the Electrophysiology Laboratory of Cardiology 
Department of the S. Chiara Hospital in Trento, 
Italy. Using a 3D bipolar voltage map registered 
with the EAM system before RFCA, patients 
suffering AF were divided into four stages, based 
on the percentage of LA fibrosis extent (FE): 
Minimal (FE<5%), Mild (5%≤FE<20%), 
Moderate (20%≤FE<35% ) and 
Severe ( ). LGE-MRI and MRA images 
were used to detect and quantify fibrosis of the 
left atrium using a threshold and 2D skeleton 
based approach. Quantification and 3D 
volumetric views of atrial fibrosis were compared 
with quantification and 3D bipolar voltage maps 
measured with EAM considering these voltage 
maps as surrogate for fibrosis. 
Results: Bland-Altman plot of the measurements of fibrosis extent based on the EAM system and on 
LGE-MRI was generated. Mean difference between the two method measurements (0.2%) confirms that 
there is no substantial bias of the LGE-MRI based fibrosis quantification (discrepancies in fibrosis 
quantification less than 4% from EAM results). The figure shows the 3D LA wall in white with 
segmented fibrosis in red for the antero-posterior and postero-anterior views, in comparison with 3D 
bipolar voltage maps of the EAM system for all the four fibrosis classes, selected as example. Bipolar 
voltage maps are reported with a color bar that is violet for potentials upper 0.5 mV (healthy 
myocardium) and reaches red for potentials lower 0.05 mV (fibrosis). Very good agreement in the 
localization of fibrosis areas is achieved. 
Conclusion: The novel 3D visualization and quantification tool based on LGE-MRI allows detection of 
cardiac left atrium fibrosis areas. This non invasive method provides a clinical alternative to EAM 
systems for quantification and localization of atrial fibrosis, proving to be clinically reliable among all 
different fibrosis stages and yielding accurate 3D volumetric views.  
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Purpose: orthopedic implants can nowadays be realized with high performance polymers such as 
polyether-ether-ketone (PEEK) and its carbon-fiber reinforced composite (CFR-PEEK) in addition to the 
most routinely used ultra-high molecular weight polyethylene (UHMWPE) [1]. These materials can be 
coated by plasma-spray or thermal-press techniques with titanium (Ti) or hydroxyapatite (HA) powders to 
improve osseointegration of the polymeric component. Polymers are radiolucent to X-rays and coatings 
may allow the visualization of the implanted device in clinical X-ray imaging without the addition of 
metallic markers. This work aimed at developing a synthetic tissue 
equivalent phantom and checking its suitability  in estimating the 
radiological contrast of different polymeric substrates  coated with Ti or 
HA powders for orthopedic implant applications. 
Methods and materials: an X-ray tissue-equivalent modular phantom 
was designed to simulate the anatomical tissue dimensions of the 
human hip (Figure 1). Soft tissues, trabecular bone and cortical bone 
were differentiated within the phantom by using three tissue-equivalent 
synthetic materials. Seven different substrate-coating combinations 
were considered. For each of them the substrate thickness was also 
varied (6, 8, 10, 12 mm) thus resulting in 28 tested coupons. 
Radiographic contrast of the coupons was assessed into the phantom 
using a clinical antero-posterior pelvis image acquisition protocol  by a 
state-of-the-art clinical digital radiography apparatus. Contrast (∆PI) 
values were than compared to a minimum contrast threshold for 
detectability (∆PIT=0.05) in compliance with ASTM 640-07 [2]. 
Results: contrast values (∆PI) of tested coupons ranged from 0.02 to 
about 0.27. Both the polymeric substrate and the coating contributed to 
the measured contrast of the coupons, depending on the combination of 
polymer type, substrate thickness, coating material, coating thickness 
and porosity. A sufficient radiographic contrast was found in 18 out of 
the 28 tested coupons. Thin titanium coatings resulted in a sufficient 
contrast when deposited on PEEK or CFR-PEEK thicker than 10 mm. Medium thickness coatings with 
little porosity and thick coatings with higher porosity were above the threshold when associated to 8 mm 
or more of CFR-PEEK. Differently, titanium alloy pre-sintered grid was clearly distinguished even when 
attached to 6 mm thin UHMWPE. 
Conclusion: the proposed phantom represent a valid tool to assess detectability of polymeric coated 
implants by X-ray plain radiography. Considering the wide range of coatings and polymers nowadays 
available, information obtained from the tissue-equivalent phantom are essential in optimizing micro and 
macro design of polymeric coated implants. 
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Provincia Autonoma of Trento (project “Inspired”). 
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Purpose: Overranging (OV) increases the dose delivered to patients undergoing helical Computed 
Tomography (CT) examinations. This side effect of multislice helical CT is due to X-ray data 
interpolation along the craniocaudal direction z. With reference to figure, the delivered dose to patient is 
described by the accumulated total dose profile D(z), its 
equilibrium value Deq(0) at the scan centre z=0,  and 
Dose Line Integral (DLI), represented as the gray area. 
The ratio DLI/Deq(0) defines the scan length L. OV is 
given by subtraction of the imaged Planned Length 
(PL), indicated on the operator’s console, from the L 
value. OV leads to some concerns, especially when 
radiosensitive organs are in close proximity to the scan 
extremes. This work proposes and evaluates an 
alternative  new method of estimating the OV in helical 
CT, using a real-time dosimetry based on a standard 
pencil chamber (PC). The OV values (OVr-t) are compared with those obtained from measurements with 
film (OVfilm), considered the benchmark technique. The new method is suitable for modern scanners 
equipped with adaptive collimation (AC) (i.e. the dynamic closure of the X-ray collimators at the scan 
extremes). This method extends the dose-slope method proposed by van der Molen [1], in which OV is 
quantified without films only on CT scanners without AC. 
Methods and materials: The OVfilm was measured direct from the dose profile, by subtracting PL from 
Lfilm using Gafchromic films (GF type XR-QA2 ISP). The OVeff was evaluated by means of a PC coupled 
to an electrometer (10X5-3CT Radcal Corporation) with a charge-collection-length of 100 mm. Two 
different PC settings were alternatively selected: the Dose Rate mode (DR), providing one reading per 
second (measurement denoted as RDR and expressed in mGy.cm/min units) and the Dose Accumulate 
mode (DA), providing an integral reading (RDA in mGy.cm units). The OVr-t was then quantified as: OVr-t 
= Lr-t - PL = v·(RDA/RDR) - PL, with the scan speed v calculated as: nominal collimation·pitch / rotation 
time. The OVr-t evaluation method was tested on three CT scanners. They were a Philips Brilliance 16S 
installed at the S. Chiara Hospital of Trento (Tomograph A) not equipped with AC, a Siemens Somatom 
Definition AS 128S operating in the same hospital (Tomograph B), and a General Electric Discovery TM 
CT750 HD 64S installed at the S.M. della Misericordia Hospital, Udine (Tomograph C). In an attempt to 
evaluate a wide range of OV values, very different CT scans were considered. 
Results: OVr-t and OVfilm have a good overlap for all Tomographs with absolute discrepancies always less 
than 2.1 mm. This means that all discrepancies are less than 10% of the measured absolute values. These 
results are in agreement with other OV evaluations based on van der Molen method. Moreover the new 
real-time OV evaluation approach proposed in this work can be used also for modern CT scanners with 
AC.  
Conclusions: The present study proposes an uniform approach in OV evaluation, i.e. not depending on 
the presence or not of AC. The real-time PC based approach described is satisfactory as regards accuracy 
as well as precision. Advantages of the new method are its simplicity of implementation, because only a 
standard PC is required, the cost and time saving and the elimination of tedious procedures required by 
films. 
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Hadrontherapy is a promising radiotherapy technique, expecially for tumors that are in proximity of 
critical organs, because it offers the possibility to deliver high dose in well-defined volumes. Its 
effectiveness is relies on the knowledge of the position of the Bragg peak within the patient, that can be 
calculated from the well known Bethe-Bloch equation. The precision of the treatment could be impaired 
if the range during the treatment varies from the calculated one, due to the temporary physiological 
modifications of organs and tissues. Positron Emission Tomography (PET) is one of the techniques which 
allows to control the Bragg peak location during the treatment. 
The INSIDE project aims to develop a dedicated in-beam PET scanner (Figure 1) for head and neck 
region able to reconstruct the Bragg peak position after a fraction of the dose delivered to the patient and 
capable of handling the expected count rate during the treatment. 
The PET scanner will be made by two planar heads, each 10 cm (axially) x 25 cm (transaxially), with a 
gantry aperture of about 55 cm. Each head is composed of 2 x 5 pixelated LFS scintillator matrices of 5 x 
5 cm2, with 16 x 16 pixels (3 x 3 x 20 mm3) of 3.2 mm picth. Each scintillator is coupled to a matrix of 16 
x 16 Multi-Pixel Photon Counters (MPPC) arrays from Hamamatsu with a one-to-one crystal-detector 
coupling. 
Every detector is connected to a 4 custom-designed 64-channels TOF-PET ASIC [1]. Its read-out 
channels are composed of an analougue front-end that amplifies the input signal and delivers two digital 
signals to a mixed-mode TDC, which output is a data set containing information on the time of the trigger 
and the time-over-threshold of the processed input signal. 
Each front-end is controlled by a FPGA-based board that calibrates the data and prepares the event data-
packet for its transmission to a central processing board (mainboard). The mainboard manages the overall 
data streaming, the system status and configuration, and performs real-time coincidence detection by 
timestamp comparison. All the coincident events are then transmitted to the host PC via USB connection 
and are used for image reconstruction. 
The detected coincidences are used to measure the activation line integrals across the target. Each line 
integral is used to reconstruct the spatial activity distribution map through a MLEM reconstruction 
algorithm. 
An important part of this project is the extension of the in-beam PET technique to Carbon therapy. In fact, 
the projectile fragmentation at the end of the Carbon range could produce an undesired dose deposition 
beyond the biological target volume. To measure the fragments produced by therapeutic Carbon beams a 
dedicated dose profiler will be build. It will make possible the measure of the distal fall-off dose 
distribution derived from the additional fragments. The traker will be made by 6 planes with 2 cm spacing 
and a position sensitive calorimeter for the measurement of the proton energy. Each plane is composed by 
2 stereo layers of 192 0.5x0.5 mm2 scintillator fibers read out by 96 1 mm2 MPPC. The calorimeter is 
composed of 4x4 LYSO pixellated crystals of 50x50x16 mm3 each one read out by 64 channel 
Hamamatsu MultiAnode. 
The treatment outcome is verified by comparing the activity image to the simulated one. The tool used for 
the calculations of particle transport and interaction with matter is FLUKA [2]. Comprehensive geometry 
and measurements model has been developed by the collaboration, including PET heads, dose profiler, 
beam pipe and nozzle, target (phantom or patient CT), treatment plan and custom post-processing tools 
for PET data analysis. 
In this work we show the results obtained in the beam tests at the CNAO facility of Pavia. 
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 Figure 1: Sketch of the mechanical structure of the scanner (on the left) and its placement in a treatment 
room of the CNAO facility of Pavia (on the right). 
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The development of Neutron Capture Therapy (NCT) for cancer treatments has stimulated the research 
for beam characterization in order to optimize the therapy procedures. The NCT  has found to be 
promising for treatments of tumours which hardly can be treated with other techniques such as gliomas. 
Alongside with the improvements of this technique, the development of techniques for the beam 
characterization arouses great interest in order to optimize the therapy procedures by reliably determining 
the various (neutronic and photonic) components of the mixed beam usually employed for therapy. 
In the last years there is a large interest in alanine Electron Spin Resonance (ESR) dosimetry for electron 
and photon beams. Furthermore, recently the applications of ESR dosimetry for high LET radiation 
beams such as carbon ions and neutrons are continuously increasing. This is because of the very good 
dosimetric features of alanine EPR detectors such as: tissue equivalence, linearity of its dose-response 
over a wide range, high stability of radiation induced free radicals, no destructive read-out procedure, no 
sample treatment before EPR signal measurement and low cost of the dosimeters [1]. Moreover, in order 
to improve the sensitivity to thermal neutrons of alanine dosimeters the addition of additive nuclei such as 
Gd2O3 was previously studied [2]. 
The choice of Gd as additive nucleus is due to its very high capture cross section to thermal neutrons and 
to the possibility for secondary particles produced after interaction with thermal neutrons of releasing 
their energy in the neighbourhood of the reaction site. In particular, it was found that low concentration 
(i.e. 5% by weight) of gadolinium oxide brings about an neutron sensitivity enhancement of more than 10 
times without heavily reducing tissue equivalence [3]. 
 
 
Fig.1 – (Left) Alanine pellets; (Right) Alanine pellets with Gd2O3. 
 
In this work we have studied the response of alanine pellets with and without gadolinium exposed to the 
thermal column of the Mainz reactor. Pure alanine dosimeters (Fig.1 - left) used were produced by 
Synergy Health (Germany) whereas the Gd-added dosimeters were produced at the University of Palermo 
(Fig.1 - right). The irradiations were performed inside polyethylene holders to guarantee charged particles 
equilibrium conditions. ESR measurements were carried out through Bruker ECS106 spectrometer 
equipped with a TE102 rectangular cavity.  
The results of ESR experiments are compared to Monte Carlo (MC) simulations [4] aimed at obtaining 
information about the contribution of the various (neutronic and photonic) components to the total dose 
measured by means of ESR dosimeters (Fig.2). For alanine dosimeters a good agreement between 
experimental data and MC simulation have been achieved. 
 
 
 
Fig.2 –Measured and calculated (through MC simulation) dose values of alanine pellets in PMMA. 
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The analysis of diffusion tensor imaging (DTI) allows to evaluate in vivo and in a non-invasive way the 
process of diffusion of water molecules in biological tissues. The peculiar organization of some biological 
tissues influences this phenomenon  making it anisotropic and therefore well evaluable with these 
techniques. Changes in tissue anisotropy can also be found in many diseases without any signal intensity 
variation on conventional MR pulse sequences since they are intimately related to intrinsic micro-
structural changes. 
Despite all these important applications, DTI fails to fully utilize the MR diffusion measurements that are 
inherent to tissue microstructure. DTI implicitly assumes that water molecule diffusion occurs with a 
Gaussian distribution of diffusion displacement. This assumption has been experimentally demonstrated 
to be not always suitable in both white matter and gray matter. 
In biological tissue, complex underlying cellular components and structures hinder and restrict the 
diffusion of water molecules. Moreover, the simplified description of the diffusion process in vivo by a 
2nd-order 3D diffusion tensor prevents DTI from being truly effective in characterizing relatively 
isotropic tissue such as GM. Even in WM, the DTI model can fail if the tissue contains substantial 
crossing or diverging fibers. 
Jensen et al. [1] introduced diffusion kurtosis imaging (DKI), a higher order diffusion model that is a 
straightforward extension of the DTI model. DKI is an approximation of the logarithmic expansion of the 
DWI signal decay up to the b2 term and neglects the b3 terms. DKI give an dimensionless measure that 
quantifies the deviation of the water diffusion displacement profile from the Gaussian distribution of 
unrestricted diffusion, providing a measure of the degree of diffusion hindrance or restriction. 
 
   
a b c d e f g 
Fig.1 – (a) mean diffusivity (MD); (b) radial diffusivity (RD); (c) fractional anisotropy (FA); (d); color 
encoded fractional anisotropy (decFA); (e) mean kurtosis (MK); (f) assial kurtosis (AK); (g) radial 
kurtosis (RK). 
 
The extensive application of DKI in a clinical routine must deal with several difficulties. The most 
important is the long acquisition time (much more time than that required for the DTI). 
In clinical applications the real issues is to find a good compromise between acquisition time and 
robustness of the fit [2]. Another major problem of DKI is that these DWI images are usually acquired 
with an echo planar imaging (EPI) sequence and also require high b-values, resulting in a low SNR of 
acquired diffusion weighted images. Distortion correction so is an important step in DKI. However, in 
order to become a routine procedure, DKI still needs to be improved in terms of robustness, reliability, 
and reproducibility. The lack of standard procedures for post-processing, especially for noise correction, 
might become a significant issue for the use of DKI in clinical routine. 
The aim of this work is the description of the theory of Diffusion Kurtosis Imaging (DKI), the MRI 
protocol that we used for DKI acquisitions at 1.5T clinical scanner. Some examples of DKI maps 
obtained by us are shown in Fig.1. 
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Functional magnetic resonance imaging (fMRI) is a safe, noninvasive and repeatable MRI technique, 
used to estimate and localize neuronal activation in the gray matter of the brain, with high spatial 
(millimeters) and temporal resolution (in the order of seconds). 
This technique is based on the principle of neurovascular coupling, which implies that an increase in 
neuronal activity will cause a rise in blood oxygen consumption and a concomitant rise in local cerebral 
perfusion. This increased blood flow to the activated region alters the ratio between the deoxyhemoglobin 
and oxyhemoglobin. Deoxyhemoglobin is paramagnetic and, therefore, influences the signal registered in 
the MRI. This is the so called blood oxygenation level dependent (BOLD). The BOLD response reflects 
the degree of oxygenation of the blood in capillaries supplying brain tissue, and its neurophysiological 
basis lies in changes to blood flow and level of oxygenation in response to neuronal activity. That changes 
in the BOLD signal indirectly reflect neuronal activity. 
During fMRI experiments, the brain of the subjects is scanned repeatedly, usually using the fast imaging 
technique of echo planar imaging (EPI). 
In the fMRI experiment the subject is required to carry out some task consisting of periods of activity and 
periods of rest or rest quietly in the scanner without any task (resting-state fMRI). 
Resting state fMRI focuses on spontaneous low frequency fluctuations (< 0.1 Hz) in the BOLD signal; 
investigates synchronous activations between regions that are spatially distinct (functional connectivity), 
occurring in the absence of a task or stimulus [1]. 
Functional connectivity is essentially a statistical concept. Unlike anatomical connectivity, which 
describes physical pathways of information exchange (and which can be obtained by means of MR 
tractography), functional connectivity describes the correlation of spatially remote areas in the temporal 
domain. Dependence is calculated between all elements of a system, whether these elements are 
connected by direct or indirect structural links. Functional connectivity relies primarily on traditional 
fMRI techniques, but takes advantage of low BOLD frequency fluctuations to examine intrinsic activity 
in the brain. Functional networks generated using this method have been termed 'resting-state networks’ 
(RSNs). 
The target of this work is to investigate the connectivity variation during time, after a particular external  
stimulus or after drugs administration.  
The method used to explore changes or modulations of the functional architecture of brain networks is the 
group PICA analysis (probabilistic independent component analysis), a statistical technique that separates 
a set of signals into independent uncorrelated components. The result is a set of ICs (Independent 
Components) some of which are clearly related to neuronal networks and others linked to physiological 
processes or artifacts.  
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In the last years, the development of Neutron Capture Therapy (NCT) [1] for cancer treatments has 
stimulated the research for beam characterization in order to optimize the therapy procedures. The success 
of radiation therapy in treating cancer depends on the delivery of lethal radiation dose to the tumour, with 
as little as possible harm to surrounding tissues. 
Several research laboratories have shown an increasing interest aimed at extending the applicability of 
Electron Spin Resonance (ESR) dosimetry to radiotherapy with different types of radiation beams. In 
particular, ESR spectrometry provides absorbed dose measurements through the detection of the stable 
free radicals produced by ionizing radiations. The ESR dosimetric method has many advantages such as 
simple and rapid dose evaluation, the readout procedure is non-destructive, linear response of many 
organic and inorganic compounds [2]. ESR detectors show a behavior that suggest possible applications 
for various kinds of beams used for radiation therapy. Nowadays, the most widely used organic 
compound as a dosimeter is the alanine [3]. However, many researches are in progress with the aim at 
improving sensitivity of ESR dosimetry for doses much smaller than 1 Gy. 
These works are focused on the investigations of new materials or new mixtures of organic and/or 
inorganic compounds with suitable features, such as high efficiency of radiation-matter energy transfer 
and radical stability at room temperature. 
Our research group has started an investigation of the ESR response of some phenols compounds for 
possible dosimetric applications. The aim of this work is to investigate the dosimetric features of some 
phenols for applications in ESR dosimetry. Phenols are compounds possessing a benzene ring attached to 
a OH group. After irradiation the final product is a stable phenoxy radical. The stability of such radical 
can be improved by adding other alkyl chains which can be attached to the benzene ring.  
In particular, the phenol octadecyl-3-(3,5-di-tert.butyl-4-hydroxyphenyl)-propionate (IRGANOX 1076® 
phenols) gave interesting results [4]. Moreover, its high molecular weight, the low volatility and the 
compatibility with the dosimeter binding material (wax) are advantages with respect to lower molecular 
weight phenols. 
 
 
 
In this work we report the ESR investigation of on IRGANOX® 1076 phenols with and without Gd2O3 
(5% by weight) exposed to neutron beam. The choice of Gd as the additive nucleus has been made 
because we are interested in applications for mixed field (neutrons/photons) Gd-ESR dosimetry has an 
high neutron capture cross section and, furthermore, the high Linear Energy Transfer secondary particles 
release their energy entirely in the dosimeter. The low content of gadolinium guarantees a good tradeoff 
between the sensitivity to thermal neutrons and the reduction of tissue equivalence. The dosimetric 
features of these ESR dosimeters (dependence on microwave power and modulation amplitude, their 
response after gamma and neutron irradiations, the detection limits for both beam typologies, signal 
stability after irradiation) have been investigated and the results are reported. 
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The Fricke Xylenol Gel (FXG) dosimetric system is based on the radiation induced oxidation of ferrous 
(Fe2+) to ferric (Fe3+) ions [1]. 
The application of Fricke type gels for ionizing radiation dosimetry is continuously increasing worldwide 
due to their many favorable properties. However, one of their shortcomings is that ferrous and ferric ions 
diffuse in the gel matrix. To maintain the spatial integrity of the dose distribution, Fricke gels must be 
analyzed within a few hours of their irradiation, so that ferric ions remain close to their point of 
production. Thus, the spatial integrity of the dose distribution in the Fricke gel is maintained. 
The gel matrix also contributes to the oxidation of ferrous ions during irradiation, increasing the chemical 
yield of ferric ions in aqueous solution and increasing the sensitivity of the dosimeter. 
The oxidation of ferrous ions also causes a reduction of the longitudinal nuclear magnetic relaxation time 
T1 which can be measured by means of nuclear magnetic resonance (NMR) relaxometry and magnetic 
resonance imaging (MRI) [2]. 
In this work the results of our analyses of FXG dosimeters are reported. We performed NMR relaxometry 
investigations which allow for direct measurements of the relaxation times in samples exposed to clinical 
photon beams. The main dosimetric features of the NMR signal were investigated. The gels were 
irradiated in the clinical dose range between 0 and 20 Gy. In order to assess the photon sensitivity we 
analyzed the dependence of NMR relaxation time on radiation dose with varying ferrous ammonium 
sulfate content (from 0.5 mM to 5 mM) inside FXGs (Fig.1). Furthermore, signal stability was followed 
for several days after irradiation [3]. 
 
Fig.1 - FXG dose response curve for various concentrations of ferrous sulphate. 
 
These measurements were also aided by acquisitions of magnetic resonance imaging (MRI) which can 
permit 3D dose mapping [4]. In order to maximize the MRI response a systematic study was performed to 
optimize acquisition sequences and parameters. In particular, we analyzed for inversion recovery 
sequences the dependence of MRI signal on the repetition time TR and on the inversion time TI [3]. 
 
  
 
Fig.2 – (above) Picture of FXG irradiated in the clinical range  (1.75 mM); (below) MRI image obtained 
with IR sequence (TR=400ms and TI=2500ms). Dose increases from left to right. 
 
The dose calibration curves are reported and discussed from the point of view of the dosimeter use in 
clinical radiotherapy (Fig.2). This work has highlighted that the optimization of additives inside gel 
matrix is fundamental for optimizing photon sensitivity of these detectors. We can conclude that FXG 
dosimeters with optimal ferrous ammonium sulfate content can be regarded as a valuable dosimetric tool 
to achieve fast information on spatial dose distribution. 
 
[1] M. DAY, G. STEIN, Chemical effects of ionizing radiation in some gels. Nature (1990) 
DOI:10.1038/166146a0. 
[2] M. MARRALE, M. BRAI, A. LONGO, S. GALLO, E. TOMARCHIO, ET AL., NMR relaxometry 
measurements of Fricke gel dosimeters exposed to neutrons. Rad. Ph. and Ch. (2014) DOI: 
10.1016/j.radphyschem.2014.05.049. 
[3] M. MARRALE, M. BRAI, C. GAGLIARDO, S. GALLO, A. LONGO, L. TRANCHINA, B. 
ABBATE, G. COLLURA, ET AL., Correlation between ferrous ammonium sulfate concentration, 
sensitivity and stability of Fricke gel dosimeters exposed to clinical X-ray beams. NIM B (2014) DOI: 
10.1016/j.nimb.2014.05.012. 
[4] A. GALANTE, ET AL., MRI study of radiation effect on Fricke gel solutions. Rad. Meas. (2008) 
DOI: 10.1016/j.radmeas.2007.12.011. 
Development of Gold/Iron Oxide Hybrid Nanoparticles for Advanced Radiotherapy 
Filippo Benettia, Devid Maniglioa, Giorgio Speranzab, Claudio Migliaresia 
aDepartment of Industrial Engineering and Biotech Center, University of Trento, Italy 
bFondazione Bruno Kessler, Trento, Italy 
 
The key challenge in radiotherapy regards the achievement of an effective cancer treatment minimizing 
the dose released to the healthy tissues. In fact, the delivery of dose to healthy organs could provoke 
severe adverse events even long time after the treatment. A strategy to reduce the overall dose to the 
patient concerns the employment of radiosensitizing drug able to enhance the cytotoxic effects of 
radiations in the cancer region. In the last decades, several drugs have been tested for this purpose but, till 
now, the main limitation that hinders the wide diffusion of radiosensitizing drugs involves the difficulty to 
monitor the biodistribution of drugs after administration. Gold/iron oxide hybrid nanoparticles (H-NPs) 
may overcome this obstacle thanks to their biphasic structure. The radiosensitizing activity of H-NPs is 
ensured by the gold part as gold is a high atomic number element with a large cross-section for gamma-
ray scattering. Moreover, the iron oxide part allows the imaging of NPs by Magnetic Resonance Imaging 
thanks to the magnetic properties of magnetite.  
In this work, H-NPs have been synthetized and their feasibility for radiotherapy has been tested in vitro. 
The synthesis of H-NPs involved the thermal decomposition of gold and iron precursors in the organic 
phase. During the process, gold seeds are firstly created providing nucleation sites for the iron oxide 
growth. At the end, hydrophobic H-NPs with an average diameter of 25 nm are obtained, as shown by 
TEM and SAED investigations (Fig. 1). The H-NPs have been transferred in the aqueous phase using 
polysorbate, a non-toxic surfactant, which provides a hydrophilic behavior to H-NPs. The chemical 
composition of the H-NPs have been characterized using an ion-coupled-plasma optical emission 
spectrometer to evaluate the mass ratio between gold and iron.  
In vitro tests were performed to assess the cytotoxicity of H-NPs using osteosarcoma MG63 cells. In 
particular, the membrane integrity after 48h of incubation with nanoparticles was investigated revealing 
no significant difference between the H-NPs-exposed samples and the non-exposed ones. Furthermore, 
the effects over viability and proliferation of H-NPs were studied along 9 days and the results did not 
show any significant evidence of cytotoxicity related to H-NPs.  
The next stages of this work will include the study of the magnetic properties and the radiotherapy 
enhancement effects of H-NPs in vitro.   
The results about morphology, stability in physiological conditions and cytotoxicity are extremely 
encouraging and H-NPs promise to provide effective tool for advanced radiotherapy.  
 
Fig. 1 Transmission Electron Microscopy (A) and Selected Area Electron Diffraction (B) analysis of H-
NPs. 
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Purpose 
Hepato-Renal Ratio (HRR) is a method for the quantitative assessment of liver steatosis based on the 
processing of ultrasound images. 
Its reliability has been validated in literature through biopsy and 1H magnetic resonance spectroscopy. 
This paper describes a new method for ROI segmentation and HRR assessment, designed to minimize 
both inter-observer and inter-scan variability. 
 
Materials and Methods 
98 images of 32 patients were analyzed (for 23 patients multiple scans were performed). 
HRR is defined as the ratio of the gray scale mean value of the pixels within two given ROIs of the liver 
and kidney. 
Our method comprises three steps. 
In the first, the operator selects two “freehand” areas: one for the liver parenchyma and one for the renal 
cortex. The two ROIs should be as large as possible and positioned approximately at the same depth. 
In the second step, the two ROIs are "normalized" (Fig.1) as follows 
• the image is divided into sets of pixels which have the same distance from the probe(cluster) 
• for every cluster, two groups of pixels were identified, belonging to the liver ROI and kidney ROI 
respectively. The outermost pixels belonging to the largest group were deleted providing two 
groups with the same number of pixels, as closely as possible. 
 
 
 
 
 
Finally, the software smoothes out the normalized histograms of the normalized ROIs. HRR is assessed 
on the basis of these smoothed histograms. 
We call this procedure the Irregular method (IM). 
To assess inter-observer variability, ROI segmentation was repeated by a second operator using 
ellipsoidal/circular ROIs. The two ROIs were as large as possible and positioned approximately at the 
same depth. The ROIs were normalized. HRR was calculated based on the smoothed normalized 
histograms of the two normalized ROIs. We call this procedure the Ellipse method (EM). 
Outermost clusters Normalized ROIs 
Fig.1 Normalization of freehand ROIs 
 
The effectiveness of  IM was tested by comparison with a method analogous to the one presented in[1].In 
particular, two square ROIs were selected: one for the hepatic parenchyma, about 1cm2, and one for the 
renal cortex, about 0.25cm2; the centers of the two ROIs needed to be at the same y-coordinate. HRR was 
calculated based on the normalized histograms of the two ROIs. We call this procedure the Square 
method(SM). 
For each method, the ROIs should be as homogeneous as possible and positioned as near as possible to 
the image center. In this study only scans with all the normalized ROIs above 211 pixels were taken into 
account. 
In order to evaluate the inter-scan variability of a specific method, the maximum absolute HRR difference 
between the scans for each patient (MIS) was calculated. 
The effectiveness of our method, the inter-operator and inter-scan variability were assessed by Wilcoxon 
signed-rank test. 
 
Results 
In the experiment we encountered numerous difficulties using SM and EM, often obliging the operator to 
repeat the ROI segmentation. The freehand selection method facilitated this task, enabling larger areas to 
be analyzed (e.g. the mean pixel numbers were: 718 for liver Square ROIs and 1324 for normalized 
freehand ROIs). 
The differences between the HRRs obtained by our and the reference method are not statistically 
significant (IM vs.SM: P-Value=0.52 and EM vs. SM: P-Value=0.14). 
Similar results are obtained in the assessment of reproducibility (EM vs. IM: P-Value=0.46). 
In the inter-scan analysis, IM produced smaller MISs than SM (respectively: 0.19+-0.14 and 0.37+-0.23, 
P-Value<0.001). This is probably due to the large ROIs provided by IM. It is reasonable to assume that 
the larger the ROIs, the better the representation of the pathology. 
 
Conclusions 
The method presented is more user-friendly than the reference method, speeding up the procedure. It gave 
low inter-scan variability. Preliminary results seem to confirm its reproducibility and a diagnostic efficacy 
comparable to the reference method. Verification of its true effectiveness (and reproducibility) requires 
further investigation by correlation studies using histological findings. 
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Objective 
The aim of our retrospective study was to assess the incidence of hemorrhagic complications in a large 
series of patients who underwent deep brain stimulation (DBS) surgery. 
 
Background 
DBS is an effective option for the treatment of movement disorders refractory to medication, and during 
the last two decades it has became a widespread technique of proven efficacy. Despite its demonstrated 
safety, rare adverse events (AE) could result in potentially disabling outcomes, leading to further 
neurological impairment. Among them, hemorrhagic complications are the most dreaded and health-
threatening. Age and hypertension were reported to be the most significant patient-related features 
associated to an increased risk of bleeding, while intraoperative microelectrode recording (MER) and 
number of MER penetration represent the most important risk factors resulting from the surgical 
technique [1,2]. Finally, the coexistence of hypertension and MER was associated to an additional rise of 
bleeding incidence [3]. 
 
Methods 
Data of all patients submitted to DBS at our Center between 1998 and 2013 were collected. MRI and 
stereotactic CT scans were performed in all patients prior to surgery for the procedure planning. To 
minimize hemorrhagic complications, a trajectory avoiding sulci and ventricles was plotted. During all 
procedures a single-track MER approach to the target was performed, followed by an intraoperative 
microelectrode stimulation (MS) to evaluate both beneficial and side effects. When the MER did not 
show typical neuronal activity and/or MS highlighted low-threshold sustained side effects, a second or 
even third track was sequentially performed. A DBS chronic stimulation electrode was than placed along 
the best trajectory and a monopolar cathodic stimulation was finally evaluated. To rule out surgical 
complications, patients underwent an immediate postoperative CT scan and an MRI 7 days after surgery. 
A single primary surgeon executed all procedures. 
 
Results 
All procedures consisted of a single-session bilateral implantation; 221 patients received a total of 442 
definitive electrodes. 216 subjects (130 males, 86 females) were affected by Parkinson’s Disease , 3 (all 
males) by Essential Tremor, 2 by Dystonia (1m, 1f). Mean age at surgery was 60.7±6.9 years (males 
60.8±6.9; females 60.5±6.9). A total of 590 MER tracks were performed (1.33 MER per lead). 42 (19%) 
patients suffered from hypertension. Neither intraventricular nor intracerebral hemorrage occurred during 
both intraoperative and postoperative period 
 
Conclusions 
Hemorrhage is probably the most serious AE in functional neurosurgery, reported to have an overall 
incidence of 5% [1]. In our large series of patients we did not observe hemorrhagic complications, even 
though the population characteristics – age and hypertension percentage - were similar or even higher to 
those reported in literature [2,3]. Moreover, we routinely performed MER, considered a significant 
bleeding risk factor [1], especially if associated with hypertension [3]. These consideration rise the 
question whether other factors could contribute to the increase of HC risk; according to our results, a 
careful patient selection, a thorough trajectory planning, a single- rather than a multiple-track MER 
performing and the application of standardized procedures of an experienced team could prevent high rate 
of hemorrhagic events. 
 References 
1) Zrinzo L, et al. Reducing hemorrhagic complications in functional neurosurgery: a large case 
series and systematic literature review. J Neurosurg 2012;116:84-94. 
2) Xiaowu H, et al. Risks of intracranial hemorrhage in patients with Parkinson’s disease receiving 
deep brain stimulation and ablation. Parkinsonism Relat Disord 2010;16:96–100. 
3) Gorgulho A, et al. Incidence of hemorrhage associated with electrophysiological studies 
performed using macroelectrodes and microelectrodes in functional neurosurgery. J Neurosurg 
2005;102:888-96. 
 
Novel Applications of Cerenkov and Radioluminescence Imaging 
F. Boschi1, AE. Spinelli2, A. Fenzi3.  
(1) Department of Computer Science, University of Verona.  
(2) Medical Physics Department and Center for Experimental Imaging, San Raffaele Scientific Institute, 
Milan. 
(3) Department of Surgery, University of Verona. 
 
Purpose: There has been a rapid and growing interest in using small animal optical imaging systems to 
image in vitro and in vivo several radiopharmaceuticals1. The purpose of this contribution attention is to 
present the work by our group on Cerenkov luminescence imaging (CLI) and radioluminescece imaging 
(RLI).    
 
Methods and materials: CLI is based on the detection of Cerenkov radiation (CR)  due to the beta 
particles travelling in the tissues with energy greater than the Cerenkov threshold. For a beta particle in 
water the energy threshold such that β>1/n is only 260 keV and, thus, most of the isotopes used in nuclear 
medicine satisfy this condition. 
In order to investigate the possibility of detecting in vivo CR  we used a small animal optical imaging 
system composed by a back-thinned, back-illuminated CCD camera, several filters and lens. The 
instrument was used in bioluminescence mode and, thus, without using any excitation lamp.  
 
Results: We performed a comparison between micro-PET and CLI using an experimental model of 
mammary carcinoma (BB1). The tumours were obtained by subcutaneous injection of BB1 cells, which 
are epithelial cells, from spontaneous mammary carcinomas and we found a good agreement between 
PET and CLI2.  
We also investigated a multispectral 3D approach called multi spectral Cerenkov luminescence 
tomography3 (msCLT). The msCLT approach has been tested by using ex vivo tissue phantom and by 
injecting nude mice with [32P]ATP. The results obtained with phantom data showed that for a line source 
placed 6 mm below the surface the spatial resolution is 1.5 mm, this is an encouraging result considering 
that we are dealing with an optical imaging method.  
With regard to RLI we focused our attention on investigating in vitro and in vivo the more weaker 
luminescence signals induced by 99mTc. In particular in vivo imaging was performed by using nude mice 
models in order to allow the detection of a smaller number of optical photons.  
We showed that ex vivo and in vivo results further confirms the findings obtained by imaging [99mTc]MDP 
in a water solution4.      
 
Conclusion: In this contribution we presented an overview of the most recent results on the use of optical 
techniques to image radiotracers for small animal pre-clinical imaging. This novel research area has 
rapidly gain attention of several research groups and this provided a significant boost in the development 
of this field. Optical imaging offers the advantages of studying more animals at once and it is possible to 
acquire whole body planar images of small animals within few minutes.  
We also showed that dynamic CLI can be easily performed in order to study the whole body 
biodistribution of the radiopharmaceuticals.  
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Introduction: There is evidence[1] that high energy radiotherapy may damage Cardiac Implantable 
Electronic Devices (CIEDs) placed outside the field of view of direct beam γ irradiation and well away 
from it. Fast neutrons produced by linear accelerators during high energy (Ethreshold>7MeV)  radiation 
treatments are likely to be the cause of these malfunctioning. 
Purposes: The aim of this work is to assess the risk and causes of failure of CIEDs in patients 
undergoing high energy radiation treatments for prostate cancer. 
Materials and Methods: Four prostate-like radiotherapy irradiations were performed with a 15 MV 
VARIAN CLINAC 2100C linear 
accelerator, to evaluate thorax neutron 
dose and the behaviour of a sample of 
CIEDs. 
Three types of dosimeters were used, 
with two different anthropomorphic 
phantoms and different models of CIEDs, 
both Pacemakers (PMs) and Implantable 
Cardiac Defibrillators (ICDs), previously 
explanted for different reasons except 
malfunctions.  
First of all both fast and thermal 
neutron doses were evaluated placing 
bubble dosimeters inside the phantoms. 
The first one, called Jimmy, was built for 
neutron dosimetry by the Turin INFN 
section in collaboration with the Ispra 
Joint Research Center. It represents the 
upper body of an average-male and it has 
16 cavities in correspondence to critical 
organs. The second one, called Ryan, was 
designed and assembled in the Physics 
Department of the University of Trieste 
especially to perform these measurements. It represents the whole body of an average-man and has 42 
cavities, some of them in correspondence to critical organs. The larger amount of thermalizing mass of 
the second phantom appeared to be better for evaluating CIEDs malfunctioning caused by thermal 
neutrons. 
Secondly a total of 59 devices, 34 PMs and 25 ICDs were analyzed and then irradiated. No 
malfunctions were detected before the treatment, simulating a course of typical radiotherapy (70 Gy) for 
prostate cancer, according to existing protocols. During the irradiation the total thermal neutron dose was 
evaluated with CR-39 track detectors. Photon dose to the devices was measured to be lower than 1Gy, as 
required by the manufacturers[2], and electromagnetic field was measured to be negligible. 
The four standard prostate treatments were carried out as follows: two treatments to the Jimmy 
phantom, one of which with all collimators closed and two to the Ryan phantom, one of which with a fast 
neutron shield. 
Results: As a consequence of the treatments, a malfunction (memory reset, generator failure, magnet 
deactivation, VVI back-up) was found in 18 (52%) ICDs and 6 (18%) PMs. The mean measured total 
neutron dose in the CIED region was 18.9±3.8 mSv, while the dose measured with shield was 7.7±1.5 
mSv.  
Evidence of neutron capture reactions inside the CIEDs emerged by the study of the weak activation 
signal in the devices, with a High Purity Germanium Detector for γ spectroscopy. Doses from activation 
were negligible from the point of view of radioprotection. The shield shows to be effective in both 
reducing neutron dose and neutron capture induced activity. 
Conclusions: High energy radiotherapy treatments may determine malfunctioning of CIEDs due to the 
production of neutrons and following capture reactions. Failures are more frequent in ICDs than in PMs. 
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Introduction: New frontiers of medicine take into account the use of different kinds of radiations, 
including neutron beams for Boron Neutron Capture Therapy (BNCT). It is well known that high-energy 
radiotherapy beams contain contaminant neutrons that are able to damage electronic devices. This 
scenario highlights the necessity to have specific and well-working neutron shielding. A new chemical 
composition was studied in order to improve shields already available on the market. 
Purpose: The aim of this work is to build, simulate and test a neutron shield. It can be used whenever 
there is a neutron field that can both damage electronic devices and give an unwanted dose to individuals. 
 
Materials and Methods: Neutrons interact with matter in a different way with respect to charged 
particles and their behaviour is strongly dependent on the energy. One way to shield neutrons is to employ 
their capture reactions, which have an inverse square root energy dependence. For this reason it is not 
difficult to shield thermal neutrons (E<0.1 eV), while fast (E>10 keV) and epithermal (in between energy 
region) neutrons spectra have to be degraded to the thermal one with an heterogeneous shield. It is 
important to shield fast neutrons because their contribution to the effective dose is huge compared to the 
thermal one. The conversion fluence-to-dose factor is indeed non-linear in energy and presents a peak for 
E>1 MeV. In designing a shield, it is also important not to produce radioactive nuclei and γ-dose as 
reaction products and to use safe and cheap materials. 
Many shields for thermal neutrons -e.g. Flex Boron[1]- contain boron, which has a high neutron 
capture cross section. At the Physics Department of the University of Trieste, it has been designed, 
simulated and built Quick Boron (QB)[2], a shield containing boron carbide (B4C). It is available in a 
carbon fiber based rigid version (50% B4C mass percentage) and a flexible one (57% B4C mass 
percentage). The first one was tested both with simulations and experimental measurements. 
Simulations were performed with Geant4, a toolkit developed by an international collaboration 
including CERN. The QB shield was compared to polyethylene, epoxy resin and pure boron carbide 
shields. The QB attenuation law was also studied. Moreover a heterogeneous shield composed by 
polyethylene and QB was studied for non-thermal neutrons. 
Experimental verifications were performed using neutrons from a medical linear accelerator VARIAN 
CLINAC 2100C[3]. Neutron doses beyond gradually increasing QB thickness and the heterogeneous 
shield were evaluated using CR-39 track detectors and bubble dosimeters. 
Results: Simulations highlight the B4C effectiveness as a shielding material. QB indeed seems to be a 
better solution compared with other materials. A neutron attenuation law well fits simulated data for 
thermal energies. Half Value Length (HVL) obtained is ≅7.5 times shorter than for Flex Boron. 
Neutrons flux attenuation factors at 10 eV are ≅0.24 for the homogeneous and ≅0.98 for the 
heterogeneous shield. 
Experimental thermal and fast neutrons doses decrease by about 36% and 49% respectively using the 
heterogeneous shield. Data taken with various QB thickness confirmed its good shielding property.  
Conclusions: Quick Boron shield is a good choice in all studied situations. Furthermore it’s cheap, 
transportable, safe, it presents some  features even better than other commercial solutions and appears 
suitable for medical environments. 
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Introduction: Whenever a radiation field is used in therapy it is appropriate to perform dosimetric 
evaluations for radiation protection and phantoms are widely use to this scope. The evidence of neutron 
contamination of the radiation fields during high energy radiation therapy requires a neutron interaction 
specific anthropomorphic phantom. The lack of such phantoms in literature lead us to design and build 
Ryan: a new man-like full-size phantom.  
 
Purpose: The aim of this work is to reproduce neutrons interactions in the patients, by means of a 
phantom with average male-body dimensions and proportions. 
 
Materials and Methods: Scattering with nuclei is the main interaction to take into account for the 
purpose of this work. During elastic scattering the fractional kinetic energy lost by neutrons is highest for 
lowest mass target nuclei. For this reason scattering on hydrogen atoms is the most relevant for neutron 
thermalization inside the human body. 
Looking to the mean human body composition, in particular for the upper part, hydrogen (H) is present 
for 0.10 mass fraction. For this reason polyethylene (0.14 H mass fraction) is a good choice for the 
construction of a neutron phantom. Neutrons in the thorax region are likely to come from every direction, 
even from the lower part of the body, because of scattering. So, designing a neutron phantom, it is 
important to take into account also lower limbs. Finally, a phantom must present cavities for dosimeters, 
especially at critical organs positions. 
Taking into account all the previous considerations, our group at the Physics Department of University 
of Trieste built Ryan, an anthropomorphic phantom suitable for evaluating neutron doses. 
The phantom Ryan is entirely composed by polyethylene; it has 42 cavities for the positioning of 
bubble dosimeters, CR-39 track detectors and biological samples. The thorax is composed by several 
square slabs that can be rotated one with respect to the other, in order to arrange the dosimeters 
allocations as necessary. Moreover the phantom Ryan represents the whole human male body. During 
construction particular attention was devoted to respect male body proportions as described in 
literature[1]. 
The phantom Ryan is made by separable blocks so that it is easy to move, transport and store it. Each 
block is proportioned to its equivalent human body anatomic structure. These features allow the phantom 
to be also arranged in a sitting position. 
For future developments and uses of Ryan, its geometry was also implemented in Geant4, a toolkit for 
the simulation of the passage of particles through matter. 
In order to test the properties of the phantom Ryan, measurements were performed in the neutron field 
produced by a 15 MV VARIAN CLINAC 2100C medical linear accelerator. Neutron dose was evaluated 
with both bubble dosimeters and CR-39 track detectors. Results were then compared to those obtained 
with the well-known phantom Jimmy[2], in the same experimental conditions. 
 
Results: Phantom Ryan has a height of 1.73 m and  weighs 71.0 kg; its mean density is 0.96 g/cm3. 
Neutron doses evaluated in phantoms Ryan and Jimmy are in good agreement with each other. 
 
Conclusion: Looking at results, anthropomorphic phantom Ryan is suitable for a good evaluation of 
neutron doses inside human body. Furthermore it is inexpensive, handy, well proportioned and it is 
perfect for routine measurements both in sitting and supine position. In conclusion Ryan can be 
considered a good phantom for neutron dosimetry. 
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Purpose: Genomic instability has been recently defined as one of the key hallmarks enabling cancer 
development and progression [1]. Indeed DNA damage and mutability endow cancer cells with genetic 
alterations that represent the driving force of tumour progression and account for the high molecular 
heterogeneity which characterizes a tumour and its ability to escape therapeutic treatments. Physical 
agents, such as UV and ionizing radiations, are an important environmental challenge to genome stability 
and a recognized cause of human cancer. However, the ability of ionizing radiations to damage DNA is 
also exploited to kill cancer cells and is the underlying principle of radiotherapy. In our lab we study both 
the biology of the cell response to DNA damaging agents and also explore possible strategies to sensitize 
cancer cells to DNA damaging agents [2,3]. Here we focused in particular on dissecting the role of 
NONO, a multifunctional protein that is overexpressed in melanoma, compared with normal melanocites, 
in the cell response to UV radiations, which represent the main risk factor for skin cancer.  
Methods and materials: We generated NONO-silenced HeLa cell clones, through shRNA, and analyzed 
their ability to grow and activate the intra-S phase checkpoint that functions to prevent replication fork 
collapse, late origin firing and to stabilize fragile sites following UV exposure [4]. We analyzed through 
immunofluorescence whether NONO localizes to the sites of UV-induced RAD9 foci and, to position 
NONO in the complex cascade triggered by UV exposure, we analyzed the chromatin loading of various 
factors involved in the DNA damage response in the absence of NONO. 
Results: We first found that lack of NONO decreased HeLa cell growth, likely through a delay in the 
G1/S cell cycle transition. Then, we challenged NONO-silenced cells with exposure to UV radiations and 
found that NONO-silenced cells, compared with controls, continued to synthesize DNA, failed to block 
new origin firing, and impaired S345 phosphorylation of the checkpoint kinase 1 (CHK1) showing a 
defective checkpoint activation. Consistently, we found that NONO localizes at the sites of UV-induced 
DNA damage RAD9 foci. Then, we analyzed the loading onto chromatin of various intra-S-phase 
checkpoint mediators and found that NONO favours the loading of TOPBP1, a crucial activator of the 
kinase activity of ATR, the main trigger of the UV-induced DNA damage response. Strikingly, re-
expression of NONO, through a sh-resistant mRNA, rescued CHK1 S345 phosphorylation in NONO-
silenced cells.  
Conclusion: Overall, our data uncover a new role for NONO in mediating the cellular response to UV-
induced DNA damage and pave the way for future avenues of investigation addressing the potential 
therapeutic use of NONO targeting as a synthetic lethal approach with DNA damaging agents in tumours 
such as melanomas in which NONO underlies both cancer development and progression. 
References: 
[1] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. Mar 4;144(5):646-74 
(2011).  
[2] Indovina P, Marcelli E, Di Marzo D, Casini N, Forte IM, Giorgi F, Alfano L, Pentimalli F, Giordano 
A. Abrogating G2/M checkpoint through WEE1 inhibition in combination with chemotherapy as a 
promising therapeutic approach for mesothelioma. Cancer Biol Ther. 15(4):380-8 (2014).  
[3] Di Marzo D, Forte IM, Indovina P, Di Gennaro E, Rizzo V, Giorgi F, Mattioli E, Iannuzzi CA, 
Budillon A, Giordano A, Pentimalli F. Pharmacological targeting of p53 through RITA is an effective 
antitumoral strategy for malignant pleural mesothelioma. Cell Cycle 15;13(4):652-65 (2014).  
[4] Branzei D, Foiani M. The checkpoint response to replication stress. DNA Repair (Amst) 8: 1038-46 
(2009).  
Shedding light on the workings of the social brain: a fNIRS study on newborns 
Elisa Frasnelli1, Andrea Vitale1, Daniela Tosoni1, Carlo Polloni2, Giuseppe Menna2, Ermanno Baldo2, 
Marco Ioppi3, & Giorgio Vallortigara1 
 
1 Center for Mind/Brain Sciences (CIMeC), University of Trento, Corso Bettini 31, I-38068 Rovereto 
(TN), Italy 
2 Unità Operativa di Pediatria, Ospedale S. Maria del Carmine, Corso Verona 4, 38068 Rovereto (TN), 
Italy 
3
 Unità Operativa di Ostetricia e Ginecologia, Ospedale S. Maria del Carmine, Corso Verona 4, 38068 
Rovereto (TN), Italy 
 
Human newborns have been widely shown to exhibit predispositions to attend to and preferentially learn 
about conspecifics. Such predispositions have been argued to be of vital biological importance. However, 
little is known as to the extent to which these mechanisms are in place at birth and about the possible role 
of experience in influencing them. Studying them, and their physiological and neural bases, is crucial for 
an understanding of typical and atypical human development. This study is part of a wider project that has 
the originality of investigating for the first time whether (and the extent to which) the mechanisms that 
preferentially orient the attention of neonates to social stimuli are really inborn. Specifically, the current 
study exploits the advantages of near infrared spectroscopy (NIRS) to investigate the neural bases of these 
biological predispositions to attend to biological motion in human newborns. NIRS is a completely non-
invasive technique that measures changes in the concentration of oxy- and deoxy-haemoglobin thanks to 
the different optical properties of these chromophores. In this way, NIRS allows us to detect the brain 
structures activated in human newborns as they view social stimuli. 
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Purpose: Modulated scanned beam interplay with the intra-fraction target motion may result in dose 
deterioration in ion beam therapy. The magnitude of this effect was investigated with a new tool based on 
forward planning (FP) computation using the data collected at the Italian National Center of Oncological 
Hadrontherapy (CNAO) for single fields, single fractions and total treatments.  
 
Methods and materials: A forward planning tool has been developed which starting from the patient 
4DCT and using both the spot properties measurements and the corresponding prescriptions, evaluates the 
doses into the target volume and performs comparisons based on gamma index, isodose curves and Dose 
Volume Histograms (DVH). 
A time-resolved approach to the off-line reconstruction of the dose delivered during a treatment is used. A 
method has been developed which exploits the data collected in real-time by the beam monitor chambers 
and a forward planning tool in order to determine the accuracy achieved in the full treatment delivery as 
well as in predefined partial irradiations. 
 
Results: The sensitivity of the method on the deviations of the measured values from the planned beam 
positions and planned number of particles is presented. The thorough analysis of the data collected at the 
Italian National Center of Oncological Hadrontherapy (CNAO) is shown both for partial fields, single 
fields and total treatments. As a result, the negligible effects on the total dose distributions due only to the 
beam delivery uncertainties were verified for both protons and carbon ions and the results are shown.  
Based on a 4DCT, the tool can reproduce the deviations due to the organ motion simulating the treatment 
delivery (i.e. spot sequence as a function of time) and selecting the portion of the plan for the FP 
computation on the base of the respiratory phases.  
On-line applications of the method with the integration of intra-fraction target movements and using fast 
forward planning computation are also discussed. 
 
Conclusion: A novel approach to the off-line verification of the dose delivered with the modulated 
scanning ion beam radiotherapy has been developed and applied to study the treatment delivery 
performance. The developed tool is a step towards adaptive ion-therapy simulating possible on-line 
analysis of partial delivered dose distributions. Additionally, it is also expected to help the delivery 
optimization through comparisons among different motion models as well as different mitigation 
techniques. 
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Purpose: The well-defined range of ions, enabling precise dose localization, makes them favorable for 
highly conformal treatments but also sensitive to uncertainties during planning and delivery. Standard 
approaches to manage these uncertainties include methods based on safety margins and worst-case 
optimizations [1], or, alternatively, on probabilistic algorithms [2]. However, all these methods are 
limited to finding optimal conditions for a single fraction, i.e. the overall effect in terms of tumor control 
has not been evaluated. In this work, a general probabilistic method to evaluate the optimality for the full 
fractionation schedule, by means of TPC/NTCP evaluations, was presented. The method was used to 
evaluate the effects of patient setup errors and CT stochastic noise, in the case of pediatric brain tumor. 
 
Materials/methods: The method reproduced a realistic workflow of treatment planning and delivery. 
Two kinds of uncertainties were included: 1) in planning, due to erroneous input data such as noisy CT, 
resulting in a systematic error; and 2) in delivery, due to patient setup errors, in which the effects for each 
fraction are mostly statistically independent. We performed a Monte Carlo/bootstrap sampling over 
treatment fraction simulations (400, with protons and carbon ions), aimed to model the full PDF of the 
treatment outcome. Patient setup errors were included by applying random isocenter shifts, sampled from 
a Gaussian distribution with σ = 1, 2, 3 and 4 mm (PTV margin = 3 mm). CT spatially correlated noise 
was generated from a measured noise power spectrum. 
 
The PDFs of several quality indexes, such as conformity, homogeneity, and DVHs, were evaluated. P-
value 3D maps for over/underdosage probabilities were also derived (see fig.A-B). A generalization of 
the TCP/NTCP models was introduced to estimate the full treatment effect as a function of number of 
fractions and dose per fraction, accounting for interfraction dose and RBE fluctuations. 
 
Results: We found that treatments with σ>2 mm produce a TCP reduced by 15% or more with respect to 
the treatment without errors. Also, the optimality of the treatment, quantified by the maximization of the 
probability of local control without complications (P+), is shifted towards different fractionation 
schedules (see fig.C). A systematic overestimation of the range of particles (1-2 mm), due to the noise in 
CT images, was also found. Interestingly, this deviation had the same order of magnitude, but different 
sign, as the RBE correction to the proton range. 
 
Conclusions: A method was implemented to estimate the effects of stochastic uncertainties on treatment 
optimality for the full fractionation schedule in ion beam therapy. The method could be used in a 
treatment procedure to perform robust planning, including also the optimization in fractionation schedule. 
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